d

UNITED STATES

SECURITIES AND EXCHANGE COMMISSIO

N
COMMISSION

Washington, D.C. 20549

FORM

10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 2, 2023

March 31, 2024

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

________ to
________

Commission File

No. 001-06462

TERADYNE, INC.

(Exact name of registrant as specified in its charter)

Massachusetts

04-2272148

Massachusetts
04-2272148

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

600 Riverpark Drive, North Reading

,

Massachusetts

01864

(Address of Principal Executive Offices)

(Zip Code)

978-370-2700

978-370-2700

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, par value $0.125

per share

TER

Nasdaq Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant

to
Rule 405 of Regulation
S-T
(232.405 (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in
Rule 12b-2
of the Exchange Act (check one):

Large accelerated filer

Accelerated filer

Non-accelerated

filer

Emerging growth company

Smaller reporting company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2
of the Exchange Act). Yes No

The number of shares outstanding of the registrant’s only class of Common Stock as of July 31, 2023

,
April 29, 2024, was 154,013,736156,111,885 shares.





TERADYNE, INC.

INDE
X

INDEX

Page No.

Page No.

Item 1.

Financial Statements (Unaudited):

1

Condensed Consolidated Balance Sheets as of July 2, 2023March 31, 2024 and December 31, 20222023

1

 f

Condensed Consolidated Statements of Operations for the Three and Six Months ended JulyMarch 31, 2024 and April 2, 2023 and July 3, 2022

2

Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months ended JulyMarch 31, 2024 and April 2, 2023 and July 3, 2022

3

Condensed Statements of Convertible Common Shares and Shareholders’ Equity for the Three and Six Months Ended JulyMarch 31, 2024 and April 2, 2023 and July 3, 2022

4

d

Condensed Consolidated Statements of Cash Flows for the SixThree Months Ended JulyMarch 31, 2024 and April 2, 2023 and July 3, 2022

5

Notes to Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

28

27

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

37

33

Item 4.

Controls and Procedures

38

33

Item 1.

Legal Proceedings

38

34

Item 1A.

Risk Factors

38

34

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

39

35

Item 4.

Mine Safety Disclosures

39

35

Item 5.

Other Information

39

36

Item 6.

Exhibits

Exhibits40

37


PART I

Item 1:
Financial Statements

Item 1:Financial Statements

TERADYNE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

   
July 2,

2023
  
December 31,
2022
 
        
   
(in thousands,
except per share amount)
 
ASSETS
         
Current assets:
         
Cash and cash equivalents
  $613,208  $854,773 
Marketable securities
   95,199   39,612 
Accounts receivable, less allowance for credit losses of $2,232 and $1,955 at July 2, 2023 and December 31, 2022, respectively
   493,234   491,145 
Inventories, net
   347,295   325,019 
Prepayments
   560,682   532,962 
Other current assets
   14,222   14,404 
   
 
 
  
 
 
 
Total current assets
   2,123,840   2,257,915 
Property, plant and equipment, net
   437,077   418,683 
Operating lease
right-of-use
assets, net
   75,889   73,734 
Marketable securities
   104,685   110,777 
Deferred tax assets
   152,471   142,784 
Retirement plans assets
   11,514   11,761 
Other assets
   32,699   28,925 
Acquired intangible assets, net
   44,611   53,478 
Goodwill
   412,110   403,195 
   
 
 
  
 
 
 
Total assets
  $3,394,896  $3,501,252 
   
 
 
  
 
 
 
LIABILITIES
         
Current liabilities:
         
Accounts payable
  $153,157  $139,722 
Accrued employees’ compensation and withholdings
   163,653   212,266 
Deferred revenue and customer advances
   120,085   148,285 
Other accrued liabilities
   114,435   112,271 
Operating lease liabilities
   20,212   18,594 
Income taxes payable
   65,437   65,010 
Current debt
   32,806   50,115 
   
 
 
  
 
 
 
Total current liabilities
   669,785   746,263 
Retirement plans liabilities
   124,040   116,005 
Long-term deferred revenue and customer advances
   38,999   45,131 
Long-term other accrued liabilities
   16,475   15,981 
Deferred tax liabilities
   1,304   3,267 
Long-term operating lease liabilities
   65,079   64,176 
Long-term incomes taxes payable
   44,331   59,135 
   
 
 
  
 
 
 
Total liabilities
   960,013   1,049,958 
   
 
 
  
 
 
 
Commitments and contingencies (Note P)
       
SHAREHOLDERS’ EQUITY
         
Common stock, $0.125 par value, 1,000,000 shares authorized; 154,148 and 155,759 shares issued and outstanding at July 2, 2023 and December 31, 2022, respectively
   19,269   19,470 
Additional
paid-in
capital
   1,784,590   1,755,963 
Accumulated other comprehensive loss
   (30,472  (49,868
Retained earnings
   661,496   725,729 
   
 
 
  
 
 
 
Total shareholders’ equity
   2,434,883   2,451,294 
   
 
 
  
 
 
 
Total liabilities and shareholders’ equity
  $3,394,896  $3,501,252 


  
 
 
  
 
 
 

 

 

March 31,
2024

 

 

December 31,
2023

 

 

 

(in thousands,
except per share amount)

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

707,403

 

 

$

757,571

 

Marketable securities

 

 

41,300

 

 

 

62,154

 

Accounts receivable, less allowance for credit losses of $1,947 and $1,988 at March 31, 2024
   and December 31, 2023, respectively

 

 

426,333

 

 

 

422,124

 

Inventories, net

 

 

314,232

 

 

 

309,974

 

Prepayments

 

 

537,642

 

 

 

548,970

 

Other current assets

 

 

16,057

 

 

 

37,992

 

Current assets held for sale

 

 

22,426

 

 

 

23,250

 

Total current assets

 

 

2,065,393

 

 

 

2,162,035

 

Property, plant and equipment, net

 

 

457,248

 

 

 

445,492

 

Operating lease right-of-use assets, net

 

 

74,625

 

 

 

73,417

 

Marketable securities

 

 

121,905

 

 

 

117,434

 

Deferred tax assets

 

 

185,734

 

 

 

175,775

 

Retirement plans assets

 

 

11,449

 

 

 

11,504

 

Other assets

 

 

45,098

 

 

 

38,580

 

Acquired intangible assets, net

 

 

30,234

 

 

 

35,404

 

Goodwill

 

 

407,576

 

 

 

415,652

 

Long-term assets held for sale

 

 

11,458

 

 

 

11,531

 

Total assets

 

$

3,410,720

 

 

$

3,486,824

 

LIABILITIES

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

153,873

 

 

$

180,131

 

Accrued employees’ compensation and withholdings

 

 

121,144

 

 

 

191,750

 

Deferred revenue and customer advances

 

 

100,058

 

 

 

99,804

 

Other accrued liabilities

 

 

101,275

 

 

 

114,712

 

Operating lease liabilities

 

 

17,400

 

 

 

17,522

 

Income taxes payable

 

 

55,922

 

 

 

48,653

 

Current liabilities held for sale

 

 

4,687

 

 

 

7,379

 

Total current liabilities

 

 

554,359

 

 

 

659,951

 

Retirement plans liabilities

 

 

134,878

 

 

 

132,090

 

Long-term deferred revenue and customer advances

 

 

35,044

 

 

 

37,282

 

Long-term other accrued liabilities

 

 

16,653

 

 

 

19,998

 

Deferred tax liabilities

 

 

134

 

 

 

183

 

Long-term operating lease liabilities

 

 

65,554

 

 

 

65,092

 

Long-term incomes taxes payable

 

 

44,331

 

 

 

44,331

 

Long-term liabilities held for sale

 

 

1,938

 

 

 

2,000

 

Total liabilities

 

 

852,891

 

 

 

960,927

 

Commitments and contingencies (Note Q)

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

Common stock, $0.125 par value, 1,000,000 shares authorized; 153,757 and 152,698 shares issued
   and outstanding at March 31, 2024 and December 31, 2023, respectively

 

 

19,220

 

 

 

19,087

 

Additional paid-in capital

 

 

1,848,088

 

 

 

1,827,274

 

Accumulated other comprehensive loss

 

 

(39,739

)

 

 

(26,978

)

Retained earnings

 

 

730,260

 

 

 

706,514

 

Total shareholders’ equity

 

 

2,557,829

 

 

 

2,525,897

 

Total liabilities and shareholders’ equity

 

$

3,410,720

 

 

$

3,486,824

 

The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s Annual Report on Form

10-K
for the year ended December 31, 2022,2023, are an integral part of the condensed consolidated financial statements.

1


Table of Contents

TERADYNE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


   
For the Three Months

Ended
  
For the Six Months

Ended
 
   
July 2,
2023
  
July 3,
2022
  
July 2,

2023
  
July 3,

2022
 
              
   
(in thousands, except per share amount)
 
Revenues:
                 
Products
  $540,375  $697,954  $1,013,793  $1,323,829 
Services
   144,062   142,812   288,173   272,307 
   
 
 
  
 
 
  
 
 
  
 
 
 
Total revenues
   684,437   840,766   1,301,966   1,596,136 
Cost of revenues:
                 
Cost of products
   217,011   274,674   415,675   517,690 
Cost of services
   64,934   59,703   127,379   117,124 
   
 
 
  
 
 
  
 
 
  
 
 
 
Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below)
   281,945   334,377   543,054   634,814 
   
 
 
  
 
 
  
 
 
  
 
 
 
Gross profit
   402,492   506,389   758,912   961,322 
Operating expenses:
                 
Selling and administrative
   145,695   139,533   296,650   279,718 
Engineering and development
   105,706   111,951   211,468   220,067 
Acquired intangible assets amortization
   4,825   4,871   9,627   9,934 
Restructuring and other
   6,358   2,044   8,395   17,758 
   
 
 
  
 
 
  
 
 
  
 
 
 
Total operating expenses
   262,584   258,399   526,140   527,477 
   
 
 
  
 
 
  
 
 
  
 
 
 
Income from operations
   139,908   247,990   232,772   433,845 
Non-operating
(income) expense:
                 
Interest income
   (6,354  (951  (11,613  (1,653
Interest expense
   1,045   913   2,031   1,925 
Other (income) expense, net
   815   9,436   868   14,622 
   
 
 
  
 
 
  
 
 
  
 
 
 
Income before income taxes
   144,402   238,592   241,486   418,951 
Income tax provision
   24,352   40,805   37,905   59,236 
   
 
 
  
 
 
  
 
 
  
 
 
 
Net income
  $120,050  $197,787  $203,581  $359,715 
   
 
 
  
 
 
  
 
 
  
 
 
 
Net income per common share:
                 
Basic
  $0.78  $1.24  $1.31  $2.24 
   
 
 
  
 
 
  
 
 
  
 
 
 
Diluted
  $0.73  $1.16  $1.23  $2.07 
   
 
 
  
 
 
  
 
 
  
 
 
 
Weighted average common shares—basic
   154,760   159,563   155,332   160,805 
   
 
 
  
 
 
  
 
 
  
 
 
 
Weighted average common shares—diluted
   164,751   171,159   165,530   173,367 
   
 
 
  
 
 
  
 
 
  
 
 
 

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

 

(in thousands, except per share amount)

 

Revenues:

 

 

 

 

 

 

Products

 

$

458,433

 

 

$

473,418

 

Services

 

 

141,386

 

 

 

144,111

 

Total revenues

 

 

599,819

 

 

 

617,529

 

Cost of revenues:

 

 

 

 

 

 

Cost of products

 

 

200,763

 

 

 

198,665

 

Cost of services

 

 

59,774

 

 

 

62,444

 

Total cost of revenues (exclusive of acquired intangible
   assets amortization shown separately below)

 

 

260,537

 

 

 

261,109

 

Gross profit

 

 

339,282

 

 

 

356,420

 

Operating expenses:

 

 

 

 

 

 

Selling and administrative

 

 

149,188

 

 

 

150,955

 

Engineering and development

 

 

103,199

 

 

 

105,762

 

Acquired intangible assets amortization

 

 

4,697

 

 

 

4,802

 

Restructuring and other

 

 

4,427

 

 

 

2,037

 

Total operating expenses

 

 

261,511

 

 

 

263,556

 

Income from operations

 

 

77,771

 

 

 

92,864

 

Non-operating (income) expense:

 

 

 

 

 

 

Interest income

 

 

(7,867

)

 

 

(5,258

)

Interest expense

 

 

661

 

 

 

987

 

Other (income) expense, net

 

 

12,075

 

 

 

51

 

Income before income taxes

 

 

72,902

 

 

 

97,084

 

Income tax provision

 

 

8,705

 

 

 

13,553

 

Net income

 

$

64,197

 

 

$

83,531

 

Net income per common share:

 

 

 

 

 

 

Basic

 

$

0.42

 

 

$

0.54

 

Diluted

 

$

0.40

 

 

$

0.50

 

Weighted average common shares—basic

 

 

153,047

 

 

 

155,904

 

Weighted average common shares—diluted

 

 

162,348

 

 

 

166,308

 

The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s Annual Report on Form

10-K
for the year ended December 31, 2022,2023, are an integral part of the condensed consolidated financial statements.

2


Table of Contents

TERADYNE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)


   
For the Three Months

Ended
  
For the Six Months

Ended
 
   
July 2,
2023
  
July 3,
2022
  
July 2,
2023
  
July 3,
2022
 
              
   
(in thousands)
 
Net income
  $120,050  $197,787  $203,581  $359,715 
Other comprehensive income, net of tax:
                 
Foreign currency translation adjustment, net of tax of $0, $0, $0, $0, respectively
   2,943   (29,230  12,250   (37,307
Available-for-sale
marketable securities:
                 
Unrealized (losses) gains on marketable securities arising during period, net of tax of $(180), $(1,240), $323, and $(2,573), respectively
   (568  (4,522  1,726   (9,910
Less: Reclassification adjustment for losses included in net income, net of tax of $8, $77, $10,
$59, respectively
   28   274   33   209 
   
 
 
  
 
 
  
 
 
  
 
 
 
    (540  (4,248  1,759   (9,701
Cash flow hedges:
                 
Unrealized gains arising during period, net
of 
tax of $920, $0, $1,088, $
0
respectively
   3,270   —     3,866   —   
Less: Reclassification adjustment for losses included in net income, net of tax of $91, $0, $428, $0 respectively
   323   —     1,524   —   
   
 
 
  
 
 
  
 
 
  
 
 
 
    3,593   —     5,390   —   
Defined benefit post-retirement plan:
                 
Amortization of prior service credit, net of tax of $0, $0, $(1), $(1), respectively
   (2  (2  (3  (3
   
 
 
  
 
 
  
 
 
  
 
 
 
Other comprehensive income (loss)
   5,994   (33,480  19,396   (47,011
   
 
 
  
 
 
  
 
 
  
 
 
 
Comprehensive income
  $126,044  $164,307  $222,977  $312,704 
   
 
 
  
 
 
  
 
 
  
 
 
 

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

 

(in thousands)

 

Net income

 

$

64,197

 

 

$

83,531

 

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

Foreign currency translation adjustment, net of tax of $0 and $0, respectively

 

 

(11,457

)

 

 

9,309

 

Available-for-sale marketable securities:

 

 

 

 

 

 

Unrealized (losses) gains on marketable securities arising during period,
   net of tax of $(
221) and $503, respectively

 

 

(902

)

 

 

2,294

 

Less: Reclassification adjustment for losses included in net income,
   net of tax of $
30 and $2, respectively

 

 

106

 

 

 

5

 

 

 

(796

)

 

 

2,299

 

Cash flow hedges:

 

 

 

 

 

 

Unrealized gains arising during period, net of tax of $358 and $167, respectively

 

 

1,274

 

 

 

596

 

Less: Reclassification adjustment for (gains) losses included in net income,
   net of tax of $(
500) and $338 respectively

 

 

(1,780

)

 

 

1,200

 

 

 

(506

)

 

 

1,796

 

Defined benefit post-retirement plan:

 

 

 

 

 

 

Amortization of prior service credit, net of tax of $0 and $0, respectively

 

 

(2

)

 

 

(2

)

Other comprehensive income (loss)

 

 

(12,761

)

 

 

13,402

 

Comprehensive income

 

$

51,436

 

 

$

96,933

 

The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s Annual Report on Form

10-K
for the year ended December 31, 2022,2023, are an integral part of the condensed consolidated financial statements.

3


3

Table of Contents

TERADYNE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE COMMON SHARES

AND SHAREHOLDERS’ EQUITY

(Unaudited)

      
Shareholders’ Equity
 
   
Convertible
Common
Shares
Value
  
Common
Stock Shares
  
Common
Stock Par
Value
  
Additional
Paid-in

Capital
  
Accumulated
Other
Comprehensive
(Loss) Income
  
Retained
Earnings
  
Total
Shareholders’
Equity
 
                       
      
(in thousands)
 
For the Three Months Ended July 2, 2023
        
Balance, April 2, 2023
  $—     155,445  $19,431  $1,772,352  $(36,466 $694,145  $2,449,462 
Net issuance of common stock under stock-based plans
    52   7   161     168 
Stock-based compensation expense
      12,077     12,077 
Repurchase of common stock
    (1,349  (169    (135,668  (135,837
Cash dividends ($0.11 per share)
        (17,031  (17,031
Settlements of convertible notes
    50   6   (6    —   
Exercise of convertible notes hedge call options
    (50  (6  6     —   
Net income
        120,050   120,050 
Other comprehensive income
       5,994    5,994 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance, July 2, 2023
  $—     154,148  $19,269  $1,784,590  $(30,472 $661,496  $2,434,883 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
For the Three Months Ended July 3, 2022
        
Balance, April 3, 2022
  $—     161,053  $20,132  $1,711,690  $(19,479 $762,189  $2,474,532 
Net issuance of common stock under stock-based plans
    33   4   (1,675    (1,671
Stock-based compensation expense
      11,658     11,658 
Repurchase of common stock
    (3,206  (401    (333,933  (334,334
Cash dividends ($0.11 per share)
        (17,561  (17,561
Settlements of convertible notes
    495   62   (149    (87
Exercise of convertible notes hedge call options
    (495  (62  62     —   
Cumulative-effect of change in accounting principle related to convertible debt
        1,752   1,752 
Net income
        197,787   197,787 
Other comprehensive loss
       (33,480   (33,480
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance, July 3, 2022
  $—     157,880  $19,735  $1,721,586  $(52,959 $610,234  $2,298,596 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
For the Six Months Ended July 2, 2023
        
Balance, December 31, 2022
  $—     155,759  $19,470  $1,755,963  $(49,868 $725,729  $2,451,294 
Net issuance of common stock under stock-based plans
    631   79   (3,782    (3,703
Stock-based compensation expense
      32,409     32,409 
Repurchase of common stock
    (2,242  (280    (233,604  (233,884
Cash dividends ($0.22 per share)
        (34,210  (34,210
Settlements of convertible notes
    375   47   (47    —   
Exercise of convertible notes hedge call options
    (375  (47  47     —   
Net income
        203,581   203,581 
Other comprehensive income
       19,396    19,396 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance, July 2, 2023
  $—     154,148  $19,269  $1,784,590  $(30,472 $661,496  $2,434,883 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
For the Six Months Ended July 3, 2022
        
Balance, December 31, 2021
  $1,512   162,251  $20,281  $1,811,545  $(5,948 $736,566  $2,562,444 
Net issuance of common stock under stock-based plans
    585   73   (16,318    (16,245
Stock-based compensation expense
      25,862     25,862 
Repurchase of common stock
    (4,956  (619    (545,179  (545,798
Cash dividends ($0.22 per share)
        (35,470  (35,470
Settlements of convertible notes
    1,004   125   (306    (181
Exercise of convertible notes hedge call options
    (1,004  (125  125     —   
Cumulative-effect of change in accounting principle related to convertible debt
   (1,512    (99,322   94,602   (4,720
Net income
        359,715   359,715 
Other comprehensive loss
       (47,011   (47,011
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance, July 3, 2022
  $—     157,880  $19,735  $1,721,586  $(52,959 $610,234  $2,298,596 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 

 

 

Shareholders' Equity

 

 

 

Common
Stock
Shares

 

 

Common
Stock
Par Value

 

 

Additional
Paid-in
Capital

 

 

Accumulated
Other
Comprehensive
Income (Loss)

 

 

Retained
Earnings

 

 

Total
Shareholders’
Equity

 

 

 

(in thousands)

 

For the Three Months Ended March 31, 2024

 

Balance, December 31, 2023

 

 

152,698

 

 

$

19,087

 

 

$

1,827,274

 

 

$

(26,978

)

 

$

706,514

 

 

$

2,525,897

 

Net issuance of common stock under stock-based plans

 

 

466

 

 

 

58

 

 

 

3,758

 

 

 

 

 

 

 

 

 

3,816

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

17,158

 

 

 

 

 

 

 

 

 

17,158

 

Warrant exercises

 

813

 

 

102

 

 

 

(102

)

 

 

 

 

 

 

 

 

 

Repurchase of common stock

 

 

(220

)

 

 

(27

)

 

 

 

 

 

 

 

 

(22,068

)

 

 

(22,095

)

Cash dividends ($0.12 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(18,383

)

 

 

(18,383

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

64,197

 

 

 

64,197

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

(12,761

)

 

 

 

 

 

(12,761

)

Balance, March 31, 2024

 

 

153,757

 

 

$

19,220

 

 

$

1,848,088

 

 

$

(39,739

)

 

$

730,260

 

 

$

2,557,829

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended April 2, 2023

 

Balance, December 31, 2022

 

 

155,759

 

 

$

19,470

 

 

$

1,755,963

 

 

$

(49,868

)

 

$

725,729

 

 

$

2,451,294

 

Net issuance of common stock under stock-based plans

 

 

579

 

 

 

73

 

 

 

(3,943

)

 

 

 

 

 

 

 

 

(3,870

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

20,332

 

 

 

 

 

 

 

 

 

20,332

 

Repurchase of common stock

 

 

(893

)

 

 

(112

)

 

 

 

 

 

 

 

 

(97,936

)

 

 

(98,048

)

Cash dividends ($0.11 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(17,179

)

 

 

(17,179

)

Settlements of convertible notes

 

 

324

 

 

 

41

 

 

 

(41

)

 

 

 

 

 

 

 

 

 

Exercise of convertible notes hedge call options

 

 

(324

)

 

 

(41

)

 

 

41

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

83,531

 

 

 

83,531

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

13,402

 

 

 

 

 

 

13,402

 

Balance, April 2, 2023

 

 

155,445

 

 

$

19,431

 

 

$

1,772,352

 

 

$

(36,466

)

 

$

694,145

 

 

$

2,449,462

 

The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s Annual Report on Form

10-K
for the year ended December 31, 2022,2023, are an integral part of the condensed consolidated financial statements.

4


4

Table of Contents

TERADYNE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


   
For the Six Months Ended
 
   
July 2,

2023
  
July 3,

2022
 
        
   
(in thousands)
 
Cash flows from operating activities:
         
Net income
  $203,581  $359,715 
Adjustments to reconcile net income from operations to net cash provided by operating activities:
         
Depreciation
   45,231   44,460 
Stock-based compensation
   32,449   25,122 
Provision for excess and obsolete inventory
   11,341   6,695 
Amortization
   9,580   10,095 
Deferred taxes
   (13,571  (23,597
(Gains) losses on investments
   (4,745  8,973 
Other
   (92  522 
Changes in operating assets and liabilities
         
Accounts receivable
   (2,693  (146,384
Inventories
   (13,845  (46,682
Prepayments and other assets
   (29,584  (94,751
Accounts payable and other liabilities
   (24,514  (43,611
Deferred revenue and customer advances
   (34,938  14,163 
Retirement plans contributions
   (2,482  (2,618
Income taxes
   (13,614  10,815 
   
 
 
  
 
 
 
Net cash provided by operating activities
   162,104   122,917 
   
 
 
  
 
 
 
Cash flows from investing activities:
         
Purchases of property, plant and equipment
   (80,702  (89,743
Purchases of marketable securities
   (99,018  (247,881
Proceeds from sales of marketable securities
   35,577   143,642 
Proceeds from maturities of marketable securities
   21,997   139,652 
Proceeds from life insurance
   460   —   
   
 
 
  
 
 
 
Net cash used for investing activities
   (121,686  (54,330
   
 
 
  
 
 
 
Cash flows from financing activities:
         
Repurchase of common stock
   (227,845  (532,799
Dividend payments
   (34,184  (35,442
Payments related to net settlement of employee stock compensation awards
   (20,308  (32,780
Payments of convertible debt principal
   (17,458  (42,292
Issuance of common stock under stock purchase and stock option plans
   16,599   16,536 
   
 
 
  
 
 
 
Net cash used for financing activities
   (283,196  (626,777
   
 
 
  
 
 
 
Effects of exchange rate changes on cash and cash equivalents
   1,213   8,014 
   
 
 
  
 
 
 
Decrease in cash and cash equivalents
   (241,565  (550,176
Cash and cash equivalents at beginning of period
   854,773   1,122,199 
   
 
 
  
 
 
 
Cash and cash equivalents at end of period
  $613,208  $572,023 
   
 
 
  
 
 
 
Non-cash
investing activities:
         
Capital expenditures incurred but not yet paid:
  $1,741  $1,855 

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

 

(in thousands)

 

Cash flows from operating activities:

 

 

 

 

 

 

Net income

 

$

64,197

 

 

$

83,531

 

Adjustments to reconcile net income from operations to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation

 

 

23,354

 

 

 

22,680

 

Stock-based compensation

 

 

15,758

 

 

 

18,885

 

Provision for excess and obsolete inventory

 

 

6,177

 

 

 

5,610

 

Amortization

 

 

4,766

 

 

 

4,926

 

Deferred taxes

 

 

(9,669

)

 

 

(7,634

)

Losses (gains) on investments

 

 

10,466

 

 

 

(2,238

)

Other

 

 

787

 

 

 

108

 

Changes in operating assets and liabilities

 

 

 

 

 

 

Accounts receivable

 

 

(8,055

)

 

 

37,204

 

Inventories

 

 

(6,932

)

 

 

(23,697

)

Prepayments and other assets

 

 

11,089

 

 

 

(15,380

)

Accounts payable and other liabilities

 

 

(105,548

)

 

 

(83,208

)

Deferred revenue and customer advances

 

 

(1,444

)

 

 

(32,705

)

Retirement plans contributions

 

 

(1,421

)

 

 

(1,234

)

Income taxes

 

 

3,754

 

 

 

12,488

 

Net cash provided by operating activities

 

 

7,279

 

 

 

19,336

 

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(44,023

)

 

 

(41,444

)

Purchases of marketable securities

 

 

(16,042

)

 

 

(69,276

)

Proceeds from maturities of marketable securities

 

 

14,438

 

 

 

7,468

 

Proceeds from sales of marketable securities

 

 

20,734

 

 

 

7,929

 

Proceeds from insurance

 

 

873

 

 

 

460

 

Net cash used for investing activities

 

 

(24,020

)

 

 

(94,863

)

Cash flows from financing activities:

 

 

 

 

 

 

Repurchase of common stock

 

 

(22,117

)

 

 

(93,308

)

Dividend payments

 

 

(18,370

)

 

 

(17,165

)

Payments of convertible debt principal

 

 

 

 

 

(15,155

)

Payments related to net settlement of employee stock compensation awards

 

 

(13,115

)

 

 

(19,870

)

Issuance of common stock under stock purchase and stock option plans

 

 

16,934

 

 

 

15,997

 

Net cash used for financing activities

 

 

(36,668

)

 

 

(129,501

)

Effects of exchange rate changes on cash and cash equivalents

 

 

3,241

 

 

 

(537

)

Decrease in cash and cash equivalents

 

 

(50,168

)

 

 

(205,565

)

Cash and cash equivalents at beginning of period

 

 

757,571

 

 

 

854,773

 

Cash and cash equivalents at end of period

 

$

707,403

 

 

$

649,208

 

Non-cash investing activities:

 

 

 

 

 

 

Capital expenditures incurred but not yet paid:

 

$

3,086

 

 

$

3,823

 

The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s Annual Report on Form

10-K
for the year ended December 31, 2022,2023, are an integral part of the condensed consolidated financial statements.

5


Table of Contents

TERADYNE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Unaudited)

A. THE COMPANY

Teradyne, Inc. (“Teradyne”) is a leading global supplier of automated test equipment and robotics solutions. Teradyne designs, develops, manufactures and sells automaticautomated test systems and robotics products. Teradyne’s automaticautomated test systems are used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Teradyne’s robotics products include collaborative robotic arms, and autonomous mobile robots, (“AMRs”)and advanced robotic control software used by global manufacturing, logistics and industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Teradyne’s automaticautomated test equipment and robotics products and services include:

semiconductor test (“Semiconductor Test”) systems;
storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”);
wireless test (“Wireless Test”) systems; and
robotics (“Robotics”) products.

B. ACCOUNTING POLICIES

Basis of Presentation

The consolidated interim financial statements include the accounts of Teradyne and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. Certain prior year amounts may have been reclassified to conform to the current year presentation. The December 31, 20222023 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by United States of America generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in Teradyne’s Annual Report on Form

10-K,
filed with the U.S. Securities and Exchange Commission (“SEC”) on February 22, 2023,2024, for the year ended December 31, 2022.2023.

Preparation of Financial Statements and Use of Estimates

The preparation of consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosuresdisclosure of contingent liabilities. On an

on-going
basis, management evaluates its estimates, including those related to inventories, investments, goodwill, intangible and other long-lived assets, accounts receivable, income taxes, deferred tax assets and liabilities, pensions, warranties, contingent consideration liabilities, and loss contingencies. Management bases its estimates on historical experience and on appropriate and customary assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgementsjudgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Due to the
COVID-19
pandemic, there has been uncertainty and disruption in the global economy and our markets. Management is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of this Quarterly Report on Form
10-Q.
These estimates may change, as new events occur and additional information is obtained. Actual results may differ significantly from these estimates under different assumptions or conditions.

C. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

For

In November 2023, the six months ended July 2,Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures", which will require Teradyne to disclose significant segment expenses and other segment items used by the Chief Operating Decision Maker ("CODM") on an annual and interim basis as well as provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Additionally, Teradyne will be required to disclose the title and position of the CODM. The new standard is effective for fiscal years beginning after December 15, 2023, there wereand interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. This ASU will have no recently issued accounting pronouncements that had,impact on results of operations, cash flows or are expectedfinancial condition. Upon

6


adoption, Teradyne will apply the amendments in this ASU retrospectively to have, a material impact to Teradyne’s consolidatedall prior period disclosures presented in the financial statements.

In December 2023, FASB issued ASU 2023-09 –“Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which requires expanded disclosures relating to the tax rate reconciliation, income taxes paid, income (loss) before income tax expense (benefit) and income tax expense (benefit), requiring a greater disaggregation of information for each. The provisions of ASU 2023-09 are effective for fiscal years beginning after December 15, 2024. The amendments in this update should be applied on a prospective basis, but retrospective application is permitted. This ASU will have no impact on results of operations, cash flows or financial condition.

6

Table of Contents

D. REVENUE

Disaggregation of Revenue

The following table provides information about disaggregated revenue by timing of revenue recognition, primary geographical market, and major product lines.


 

 

Semiconductor Test

 

 

System Test

 

 

Robotics

 

 

Wireless Test

 

 

 

 

 

 

System
on-a-Chip

 

 

Memory

 

 

 

 

 

Universal
Robots

 

 

Mobile
Industrial
Robots

 

 

 

 

 

Total

 

 

(in thousands)

 

For the Three Months Ended March 31, 2024 (1)

 

Timing of Revenue Recognition

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Point in Time

 

$

229,592

 

 

$

102,436

 

 

$

58,073

 

 

$

65,893

 

 

$

19,290

 

 

$

20,914

 

 

$

496,198

 

Over Time

 

 

72,716

 

 

 

7,510

 

 

 

17,249

 

 

 

1,868

 

 

 

603

 

 

 

3,675

 

 

 

103,621

 

Total

 

$

302,308

 

 

$

109,946

 

 

$

75,322

 

 

$

67,761

 

 

$

19,893

 

 

$

24,589

 

 

$

599,819

 

Geographical Market

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

$

270,567

 

 

$

95,606

 

 

$

25,781

 

 

$

11,625

 

 

$

2,954

 

 

$

17,141

 

 

$

423,674

 

Americas

 

 

22,551

 

 

 

9,052

 

 

 

36,594

 

 

 

20,005

 

 

 

14,625

 

 

 

5,824

 

 

 

108,651

 

Europe, Middle East and Africa

 

 

9,190

 

 

 

5,288

 

 

 

12,947

 

 

 

36,131

 

 

 

2,314

 

 

 

1,624

 

 

 

67,494

 

Total

 

$

302,308

 

 

$

109,946

 

 

$

75,322

 

 

$

67,761

 

 

$

19,893

 

 

$

24,589

 

 

$

599,819

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended April 2, 2023 (1)

 

Timing of Revenue Recognition

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Point in Time

 

$

273,275

 

 

$

61,258

 

 

$

56,857

 

 

$

70,029

 

 

$

15,959

 

 

$

35,363

 

 

$

512,741

 

Over Time

 

 

73,559

 

 

 

6,917

 

 

 

17,774

 

 

 

2,008

 

 

 

1,218

 

 

 

3,312

 

 

 

104,788

 

Total

 

$

346,834

 

 

$

68,175

 

 

$

74,631

 

 

$

72,037

 

 

$

17,177

 

 

$

38,675

 

 

$

617,529

 

Geographical Market

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

$

283,259

 

 

$

63,695

 

 

$

39,590

 

 

$

13,217

 

 

$

1,502

 

 

$

23,231

 

 

$

424,494

 

Americas

 

 

41,568

 

 

 

2,944

 

 

 

28,980

 

 

 

20,447

 

 

 

11,806

 

 

 

12,846

 

 

 

118,591

 

Europe, Middle East and Africa

 

 

22,007

 

 

 

1,536

 

 

 

6,061

 

 

 

38,373

 

 

 

3,869

 

 

 

2,598

 

 

 

74,444

 

Total

 

$

346,834

 

 

$

68,175

 

 

$

74,631

 

 

$

72,037

 

 

$

17,177

 

 

$

38,675

 

 

$

617,529

 

(1)
Includes $0.9 million and $1.3 million in the three months ended March 31, 2024 and in the three months ended April 2, 2023, respectively, for leases of Teradyne’s systems recognized outside Accounting Standards Codification (“ASC”) 606 “Revenue from Contracts with Customers.”
   
Semiconductor Test
       
Robotics
            
                                
   
System
on-a-Chip
   
Memory
   
System
Test
   
Universal
Robots
   
Mobile
Industrial
Robots
   
Wireless

Test
   
Corporate

and

Eliminations
  
Total
 
                                
   
(in thousands)
 
For the Three Months Ended July 2, 2023 (1)
                                
Timing of Revenue Recognition
                                
Point in Time
 $282,080  $112,547  $76,801  $55,737  $12,770  $40,261  $—    $580,196 
Over Time
  72,614   7,467   17,471   2,116   1,011   3,562   —     104,241 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $354,694  $120,014  $94,272  $57,853  $13,781  $43,823  $—    $684,437 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Geographical Market
                                
Asia Pacific
 $303,062  $115,250  $41,644  $14,883  $2,291  $22,362  $—    $499,492 
Americas
  32,191   4,286   40,163   22,832   6,086   19,491   —     125,049 
Europe, Middle East and Africa
  19,441   478   12,465   20,138   5,404   1,970   —     59,896 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $354,694  $120,014  $94,272  $57,853  $13,781  $43,823  $—    $684,437 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
For the Three Months Ended July 3, 2022 (1)
                                
Timing of Revenue Recognition
                                
Point in Time
 $395,211  $74,790  $118,692  $80,409  $17,801  $60,765  $(193 $747,475 
Over Time
  64,253   7,094   16,010   2,104   741   3,089   —     93,291 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $459,464  $81,884  $134,702  $82,513  $18,542  $63,854  $(193 $840,766 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Geographical Market
                                
Asia Pacific
 $413,537  $78,996  $95,584  $17,357  $5,317  $44,106  $—    $654,897 
Americas
  28,714   2,552   33,409   27,732   7,229   17,460   (193  116,903 
Europe, Middle East and Africa
  17,213   336   5,709   37,424   5,996   2,288   —     68,966 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $459,464  $81,884  $134,702  $82,513  $18,542  $63,854  $(193 $840,766 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
For the Six Months Ended July 2, 2023 (2)
                                
Timing of Revenue Recognition
                                
Point in Time
 $555,354  $173,805  $133,658  $125,760  $28,735  $75,624  $—    $1,092,937 
Over Time
  146,173   14,384   35,245   4,124   2,229   6,874   —     209,029 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $701,528  $188,189  $168,903  $129,884  $30,964  $82,498  $—    $1,301,966 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Geographical Market
                                
Asia Pacific
 $586,321  $178,945  $81,234  $28,100  $3,793  $45,593  $—    $923,986 
Americas
  73,759   7,230   69,143   43,273   17,898   32,337   —     243,640 
Europe, Middle East and Africa
  41,448   2,014   18,526   58,511   9,273   4,568   —     134,340 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $701,528  $188,189  $168,903  $129,884  $30,964  $82,498  $—    $1,301,966 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
For the Six Months Ended July 3, 2022 (2)
                                
Timing of Revenue Recognition
                                
Point in Time
 $718,666  $163,513  $223,981  $163,591  $34,545  $109,194  $(539 $1,412,951 
Over Time
  127,382   14,127   29,390   4,206   1,902   6,178   —     183,185 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $846,048  $177,640  $253,371  $167,797  $36,447  $115,372  $(539 $1,596,136 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Geographical Market
                                
Asia Pacific
 $754,277  $172,147  $169,369  $35,978  $7,909  $79,052  $—    $1,218,732 
Americas
  58,428   4,598   70,017   55,880   15,793   27,147   (539  231,324 
Europe, Middle East and Africa
  33,343   895   13,985   75,939   12,745   9,173   —     146,080 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $846,048  $177,640  $253,371  $167,797  $36,447  $115,372  $(539 $1,596,136 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
(1)
Includes $1.3 million and $1.9 million in 2023 and 2022, respectively, for leases of Teradyne’s systems recognized outside Accounting Standards Codification (“ASC”) 606
“Revenue from Contracts with Customers.”
(2)
Includes $2.5 million and $4.2 million in 2023 and 2022, respectively, for leases of Teradyne’s systems recognized outside ASC 606
“Revenue from Contracts with Customers.”
7

Table of Contents

Contract Balances

During the three and six months ended JulyMarch 31, 2024 and April 2, 2023, Teradyne recognized $27.3$28.2 million and $68.4 million, respectively, that was included within the deferred revenue and customer advances balances at the beginning of the period. During the three and six months ended July 3, 2022, Teradyne recognized $25.1 million and $60.2 

$50.7million, respectively, that was included within the deferred revenue and customer advances balances at the beginning of the period. This revenue primarily relates to undelivered hardware, extended warranties, training, application support, and post contract support. Each of these represents a distinct performance obligation. As of July 2, 2023,March 31, 2024, Teradyne
had $
1,271.6
1,075.2 million of unsatisfied performance obligations. Teradyne expects to recognize
approximately
90
% of the remaining performance obligations in the next
12
months and
the remainder in 1-3 years.

7


in
1-3
years.

Deferred revenue and customer advances consist of the following and are included in short and long-term deferred revenue and customer advances on the balance sheet:

 

 

March 31,
2024

 

 

December 31,
2023

 

 

 

(in thousands)

 

Maintenance, service and training

 

$

61,404

 

 

$

66,458

 

Customer advances, undelivered elements and other

 

 

39,189

 

 

 

35,731

 

Extended warranty

 

 

34,509

 

 

 

34,897

 

Total deferred revenue and customer advances

 

$

135,102

 

 

$

137,086

 


   
July 2,
   
December 31,
 
   
2023
   
2022
 
         
   
(in thousands)
 
Maintenance, service and training
  $68,282   $78,089 
Customer advances, undelivered elements and other   46,380    59,147 
Extended warranty   44,422    56,180 
   
 
 
   
 
 
 
Total deferred revenue and customer advances
  $159,084   $193,416 
   
 
 
   
 
 
 

Accounts Receivable

During the three and six months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, Teradyne sold certain trade accounts receivables on a

non-recourse
basis to third-party financial institutions pursuant to factoring agreements. During the three months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, total trade accounts receivable sold under the factoring agreements were $59.3$23.4 million and $37.6$34.2 million, respectively. During the six months ended July 2, 2023 and July 3, 2022, total trade account
s
receivable sold under the factoring agreements were $93.5 million and $57.1 million
, respectively
. Factoring fees for the sales of receivables were recorded in interest expense and were not material. Teradyne accounted for these transactions as sales of receivables and presented cash proceeds as cash provided by operating activities in the consolidated statements of cash flows.

E. INVENTORIESASSETS HELD FOR SALE

On November 7, 2023, Teradyne entered into a definitive agreement to sell Teradyne’s Device Interface Solutions ("DIS") business, a component of the Semiconductor Test segment, to Technoprobe S.p.A. ("Technoprobe") for $85.0 million in cash. As a result, the related assets and liabilities met the criteria and were classified as held-for-sale in Teradyne’s consolidated balance sheet as of December 31, 2023. The transaction, which does not qualify as a strategic shift required for discontinued operations treatment, is expected to close in the second quarter of 2024, subject to regulatory approval.

Assets held-for-sale is comprised of the following as of March 31, 2024 and December 31, 2023:

 

 

March 31,
2024

 

 

December 31,
2023

 

 

 

(in thousands)

 

Current assets:

 

 

 

 

 

 

Inventories, net

 

$

19,276

 

 

$

17,952

 

Prepayments

 

 

3,150

 

 

 

5,298

 

Total current assets held for sale

 

 

22,426

 

 

 

23,250

 

Property, plant and equipment, net

 

 

8,994

 

 

 

8,986

 

Operating lease right-of-use assets, net

 

 

2,464

 

 

 

2,545

 

Total assets held for sale

 

$

33,884

 

 

$

34,781

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

3,954

 

 

$

6,356

 

Other accrued liabilities

 

 

323

 

 

 

552

 

Operating lease liabilities

 

 

410

 

 

 

471

 

Total current liabilities held for sale

 

 

4,687

 

 

 

7,379

 

Long-term operating lease liabilities

 

 

1,938

 

 

 

2,000

 

Total liabilities held for sale

 

$

6,625

 

 

$

9,379

 

Net assets held for sale

 

$

27,259

 

 

$

25,402

 

8


F. INVENTORIES

Inventories, net consisted of the following at July 2, 2023March 31, 2024 and December 31, 2022:


2023:

 

 

March 31,
2024

 

 

December 31,
2023

 

 

 

(in thousands)

 

Raw material

 

$

243,871

 

 

$

258,422

 

Work-in-process

 

 

39,870

 

 

 

26,851

 

Finished goods

 

 

30,491

 

 

 

24,701

 

Total inventories, net (1)

 

$

314,232

 

 

$

309,974

 

(1)
Inventories, net at March 31, 2024 and December 31, 2023 excludes $19.3 million and $18.0 million, respectively, of primarily work-in-process inventories, net classified as assets held for sale. See Note E: "Assets held for sale" for additional information.
   
July 2,

2023
   
December 31,

2022
 
         
   
(in thousands)
 
Raw material
  $250,422   $256,065 
Work-in-process
   43,685    37,982 
Finished goods
   53,188    30,972 
   
 
 
   
 
 
 
   $347,295   $325,019 
   
 
 
   
 
 
 

Inventory reserves at July 2, 2023March 31, 2024 and December 31, 20222023 were $140.3$136.0 million and $136.8$136.0 million, respectively.

F.

G. FINANCIAL INSTRUMENTS

Cash Equivalents

Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.

Marketable Securities

Teradyne’s equity and debt mutual funds are classified as Level 1 and

available-for-sale
debt securities are classified as Level 2. Contingent consideration is classified as Level 3. The vast majority of Level 2 securities are fixed income securities priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.

During the three and six months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, there were no transfers in or out of Level 1, Level 2, or Level 3 financial instruments.


8

Realized gains recorded in the three and six months ended JulyMarch 31, 2024 and April 2, 2023,

,
were $
0.1
1.0 million and $
0.4
 million, respectively. Realized gains recorded in the three and six months ended July 3, 2022
,
were $
0.1
 million and $
0.5
0.3 million, respectively. Realized losses recorded in the three and six months ended JulyMarch 31, 2024 and April 2, 2023,
,
were $
0.2
 million. Realized losses recorded in the three and six months ended July 3, 2022
,
were $
0.4
million and $
0.6
0.1 million, respectively. Realized gains and losses are included in other (income) expense, net.

Unrealized gains on equity securities recorded in the three and six months ended JulyMarch 31, 2024 and April 2, 2023

,
were $2.6$2.6 million and $4.6 million, respectively. No unrealized gains on equity securities were recorded in the three and six months ended July 3, 2022. No unrealized losses on equity securities were recorded in the three and six months ended July 2, 2023. Unrealized losses on equity securities recorded in the three and six months ended July 3, 2022
,
were $6.6 million and $8.8$
2.0 million, respectively. Unrealized gains and losses on equity securities are included in other (income) expense, net.

Unrealized gains and losses on

available-for-sale
debt securities are included in accumulated other comprehensive income (loss) on the balance sheet.

The cost of securities sold is based on average cost.

9


The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of July 2, 2023March 31, 2024 and December 31, 2022.

2023.

 

 

March 31, 2024

 

 

 

Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

 

Total

 

 

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

278,229

 

 

$

 

 

$

 

 

$

278,229

 

Cash equivalents

 

 

428,675

 

 

 

499

 

 

 

 

 

 

429,174

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

 

 

 

40,068

 

 

 

 

 

 

40,068

 

Corporate debt securities

 

 

 

 

 

35,845

 

 

 

 

 

 

35,845

 

Certificates of deposit and time deposits

 

 

 

 

 

21,706

 

 

 

 

 

 

21,706

 

Debt mutual funds

 

 

10,007

 

 

 

 

 

 

 

 

 

10,007

 

U.S. government agency securities

 

 

 

 

 

3,863

 

 

 

 

 

 

3,863

 

Commercial paper

 

 

 

 

 

1,689

 

 

 

 

 

 

1,689

 

Non-U.S. government securities

 

 

 

 

 

798

 

 

 

 

 

 

798

 

Equity securities:

 

 

 

 

 

 

 

 

 

 

 

 

Mutual funds

 

 

49,229

 

 

 

 

 

 

 

 

 

49,229

 

 

$

766,140

 

 

$

104,468

 

 

$

 

 

$

870,608

 

Derivative assets

 

 

 

 

 

4,251

 

 

 

 

 

 

4,251

 

Total

 

$

766,140

 

 

$

108,719

 

 

$

 

 

$

874,859

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

 

 

 

 

936

 

 

 

 

 

$

936

 

Total

 

$

 

 

$

936

 

 

$

 

 

$

936

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

 

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

706,904

 

 

$

499

 

 

$

 

 

$

707,403

 

Marketable securities

 

 

 

 

 

41,300

 

 

 

 

 

 

41,300

 

Long-term marketable securities

 

 

59,236

 

 

 

62,669

 

 

 

 

 

 

121,905

 

Prepayments

 

 

 

 

 

4,251

 

 

 

 

 

 

4,251

 

Total

 

$

766,140

 

 

$

108,719

 

 

$

 

 

$

874,859

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Other current liabilities

 

$

 

 

$

936

 

 

$

 

 

$

936

 

     Total

 

$

 

 

$

936

 

 

$

 

 

$

936

 

9

10


 

 

December 31, 2023

 

 

 

Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

 

Total

 

 

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

298,156

 

 

$

 

 

$

 

 

$

298,156

 

Cash equivalents

 

 

453,298

 

 

 

6,117

 

 

 

 

 

 

459,415

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

 

 

 

 

52,734

 

 

 

 

 

 

52,734

 

U.S. Treasury securities

 

 

 

 

 

41,808

 

 

 

 

 

 

41,808

 

Certificates of deposit and time deposits

 

 

 

 

 

21,772

 

 

 

 

 

 

21,772

 

Debt mutual funds

 

 

8,773

 

 

 

 

 

 

 

 

 

8,773

 

U.S. government agency securities

 

 

 

 

 

4,892

 

 

 

 

 

 

4,892

 

Commercial paper

 

 

 

 

 

1,667

 

 

 

 

 

 

1,667

 

Non-U.S. government securities

 

 

 

 

 

810

 

 

 

 

 

 

810

 

Equity securities:

 

 

 

 

 

 

 

 

 

 

 

 

Mutual Funds

 

 

47,132

 

 

 

 

 

 

 

 

 

47,132

 

 

$

807,359

 

 

$

129,800

 

 

$

 

 

$

937,159

 

Derivative assets

 

 

 

 

 

18,746

 

 

 

 

 

 

18,746

 

Total

 

$

807,359

 

 

$

148,546

 

 

$

 

 

$

955,905

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

 

 

 

 

2,545

 

 

 

 

 

 

2,545

 

Total

 

$

 

 

$

2,545

 

 

$

 

 

$

2,545

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

 

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

751,454

 

 

$

6,117

 

 

$

 

 

$

757,571

 

Marketable securities

 

 

 

 

 

62,154

 

 

 

 

 

 

62,154

 

Long-term marketable securities

 

 

55,905

 

 

 

61,529

 

 

 

 

 

 

117,434

 

Prepayments

 

 

 

 

 

18,746

 

 

 

 

 

 

18,746

 

Total

 

$

807,359

 

 

$

148,546

 

 

$

 

 

$

955,905

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Other current liabilities

 

$

 

 

$

2,545

 

 

$

 

 

$

2,545

 

Total

 

$

 

 

$

2,545

 

 

$

 

 

$

2,545

 

   
July 2, 2023
 
   
Quoted
Prices

in Active

Markets for

Identical

Instruments

(Level 1)
   
Significant

Other

Observable

Inputs

(Level 2)
   
Significant

Unobservable

Inputs

(Level 3)
   
Total
 
                 
   
(in thousands)
 
Assets
                    
Cash
  $311,803   $—     $—     $311,803 
Cash equivalents
   290,548    10,857    —      301,405 
Available-for-sale
securities:
                    
U.S. Treasury securities
   —      52,238    —      52,238 
Corporate debt securities
   —      51,608    —      51,608 
Commercial paper
   —      30,882    —      30,882 
Debt mutual funds
   7,739    —      —      7,739 
Certificates of deposit and time deposits
   —      6,699    —      6,699 
U.S. government agency securities
   —      6,475    —      6,475 
Non-U.S.
government securities
   —      544    —      544 
Equity securities:
                    
Mutual funds
   43,699    —      —      43,699 
   
 
 
   
 
 
   
 
 
   
 
 
 
   $653,789   $159,303   $—     $813,092 
Derivative assets
   —      5,819    —      5,819 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $653,789   $165,122   $—     $818,911 
   
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities
                    
Derivative liabilities
  $—     $994   $—     $994 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $—     $994   $—     $994 
   
 
 
   
 
 
   
 
 
   
 
 
 
     
Reported as follows:                    
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
                 
   
(in thousands)
 
Assets
                    
Cash and cash equivalents
  $602,351   $10,857   $—     $613,208 
Marketable securities
   —      95,199    —      95,199 
Long-term marketable securities
   51,438    53,247    —      104,685 
Prepayments
   —      5,819    —      5,819 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $653,789   $165,122   $—     $818,911 
   
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities
   .                
Other current liabilities
  $—     $994   $—     $994 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $—     $994   $—     $994 
   
 
 
   
 
 
   
 
 
   
 
 
 

10

   
December 31, 2022
 
   
Quoted 

Prices

in Active

Markets for

Identical

Instruments

(Level 1)

   
Significant

Other

Observable

Inputs

(Level 2)
   
Significant

Unobservable

Inputs

(Level 3)
   
Total
 
                 
   
(in thousands)
 
Assets
                    
Cash
  $632,417   $—     $—     $632,417 
Cash equivalents
   161,767    60,589    —      222,356 
Available-for-sale
securities:
                  —   
Corporate debt securities
   —      50,856    —      50,856 
U.S. Treasury securities
   —      39,649    —      39,649 
Commercial paper
   —      7,159    —      7,159 
Debt mutual funds
   6,580    —      —      6,580 
U.S. government agency securities
   —      6,352    —      6,352 
Certificates of deposit and time deposits
   —      1,740    —      1,740 
Non-U.S.
government securities
   —      535    —      535 
Equity securities:
                    
Mutual Funds
   37,518    —      —      37,518 
   
 
 
   
 
 
   
 
 
   
 
 
 
   $838,282   $166,880   $—     $1,005,162 
Derivative assets
   —      86    —      86 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $838,282   $166,966   $—     $1,005,248 
   
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities
                    
Derivative liabilities
   —      4,215    —      4,215 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $—     $4,215   $—     $4,215 
   
 
 
   
 
 
   
 
 
   
 
 
 
Reported as follows:
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
                 
   
(in thousands)
 
Assets
                    
Cash and cash equivalents
  $
 
 
794,184   $60,589   $—     $854,773 
Marketable securities
   —       39,612               —      39,612 
Long-term marketable securities
   44,098    66,679    —      110,777 
Prepayments
   —      86    —      86 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $838,282   $
 
166,966   $—     $1,005,248 
   
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities
                    
Other current liabilities
  $—     $4,215   $—     $4,215 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $—     $4,215   $—     $4,215 
   
 
 
   
 
 
   
 
 
   
 
 
 

The carrying amounts and fair values of Teradyne’s financial instruments at July 2, 2023March 31, 2024 and December 31, 2022

,
2023, were as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

Carrying Value

 

 

Fair Value

 

 

Carrying Value

 

 

Fair Value

 

 

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

707,403

 

 

$

707,403

 

 

$

757,571

 

 

$

757,571

 

Marketable securities

 

 

163,205

 

 

 

163,205

 

 

 

179,588

 

 

 

179,588

 

Derivative assets

 

 

4,251

 

 

 

4,251

 

 

 

18,746

 

 

 

18,746

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

 

936

 

 

 

936

 

 

 

2,545

 

 

 

2,545

 

   
July 2, 2023
   
December 31, 2022
 
   
Carrying Value
   
Fair Value
   
Carrying Value
   
Fair Value
 
                 
   
(in thousands)
 
Assets
                    
Cash and cash equivalents
  $613,208   $613,208   $854,773   $854,773 
Marketable securities
   199,884    199,884    150,389    150,389 
Derivative assets
   5,819    5,819    86    86 
Liabilities
                    
Derivative liabilities
   994    994    4,215    4,215 
Convertible debt
   32,806    115,778    50,115    139,007 
11

The fair values of accounts receivable, net and accounts payable approximate the carrying value due to the short-term nature of these instruments.

11


The following table summarizes the composition of

available-for-sale
marketable securities at July 2, 2023:
   
July 2, 2023
 
                    
   
Available-for-Sale
 
                    
   
Cost
   
Unrealized

Gain
   
Unrealized

(Loss)
  
Fair
Market

Value
   
Fair Market

Value of

Investments

with Unrealized

Losses
 
                    
   
(in thousands)
 
U.S. Treasury securities
  $56,107   $2   $(3,871 $52,238   $42,716 
Corporate debt securities
   56,680    12    (5,084  51,608    50,455 
Commercial paper
   30,311    581    (10  30,882    19,840 
Debt mutual funds
   8,104    —      (365  7,739    3,161 
Certificates of deposit and time deposits
   6,699    —      —     6,699    —   
U.S. government agency securities
   6,520    —      (45  6,475    6,475 
Non-U.S.
government securities
   544    —      —     544    —   
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
   $164,965   $595   $(9,375 $156,185   $122,647 
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
March 31, 2024:

 

 

March 31, 2024

 

 

 

Available-for-Sale

 

 

 

Cost

 

 

Unrealized
Gain

 

 

Unrealized
(Loss)

 

 

Fair
Market
Value

 

 

Fair Market
Value of
Investments
with Unrealized
Losses

 

 

 

(in thousands)

 

Corporate debt securities

 

$

39,946

 

 

$

89

 

 

$

(4,190

)

 

$

35,845

 

 

$

31,461

 

U.S. Treasury securities

 

 

44,519

 

 

 

1

 

 

 

(4,452

)

 

 

40,068

 

 

 

38,914

 

Certificates of deposit and time deposits

 

 

21,706

 

 

 

 

 

 

 

 

 

21,706

 

 

 

 

Debt mutual funds

 

 

10,363

 

 

 

 

 

 

(356

)

 

 

10,007

 

 

 

3,303

 

U.S. government agency securities

 

 

3,883

 

 

 

 

 

 

(20

)

 

 

3,863

 

 

 

3,863

 

Commercial paper

 

 

1,670

 

 

 

19

 

 

 

 

 

 

1,689

 

 

 

 

Non-U.S. government securities

 

 

798

 

 

 

 

 

 

 

 

 

798

 

 

 

 

 

$

122,885

 

 

$

109

 

 

$

(9,018

)

 

$

113,976

 

 

$

77,541

 

Reported as follows:

 

 

Cost

 

 

Unrealized
Gain

 

 

Unrealized
(Loss)

 

 

Fair
Market
Value

 

 

Fair Market
Value of
Investments
with Unrealized
Losses

 

 

 

(in thousands)

 

Marketable securities

 

$

41,308

 

 

$

19

 

 

$

(27

)

 

$

41,300

 

 

$

17,657

 

Long-term marketable securities

 

 

81,577

 

 

 

90

 

 

 

(8,991

)

 

 

72,676

 

 

 

59,884

 

 

$

122,885

 

 

$

109

 

 

$

(9,018

)

 

$

113,976

 

 

$

77,541

 

   
Cost
   
Unrealized

Gain
   
Unrealized

(Loss)
  
Fair Market

Value
   
Fair Market

Value of

Investments

with Unrealized

Losses
 
                    
   
(in thousands)
 
Marketable securities
  $95,482   $581   $(864 $95,199   $68,121 
Long-term marketable securities
   69,483    14    (8,511  60,986    54,526 
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
   $164,965   $595   $(9,375 $156,185   $122,647 
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 

The following table summarizes the composition of

available-for-sale
marketable securities at December 31, 2022:
   
December 31, 2022
 
                    
   
Available-for-Sale
 
   
Cost
   
Unrealized

Gain
   
Unrealized

(Loss)
  
Fair
Market

Value
   
Fair Market

Value of

Investments

with Unrealized

Losses
 
                    
   
(in thousands)
 
Corporate debt securities
  $57,006   $3   $(6,153 $50,856   $50,667 
U.S. Treasury securities
   44,030    —      (4,381  39,649    39,649 
Commercial paper
   7,089    70    —     7,159    —   
Debt mutual funds
   6,997    —      (417  6,580    3,095 
U.S. government agency securities
   6,442    —      (90  6,352    6,352 
Certificates of deposit and time deposits
   1,740    —      —     1,740    —   
Non-U.S.
government securities
   535    —      —     535    —   
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
   $123,839   $73   $(11,041 $112,871   $99,763 
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
12

2023:

 

 

December 31, 2023

 

 

 

Available-for-Sale

 

 

 

Cost

 

 

Unrealized
Gain

 

 

Unrealized
(Loss)

 

 

Fair
Market
Value

 

 

Fair Market
Value of
Investments
with Unrealized
Losses

 

 

 

(in thousands)

 

Corporate debt securities

 

$

56,458

 

 

$

201

 

 

$

(3,925

)

 

$

52,734

 

 

$

44,263

 

U.S. Treasury securities

 

 

45,725

 

 

 

14

 

 

 

(3,931

)

 

 

41,808

 

 

 

35,080

 

Certificates of deposit and time deposits

 

 

21,772

 

 

 

 

 

 

 

 

 

21,772

 

 

 

 

Debt mutual funds

 

 

9,081

 

 

 

 

 

 

(308

)

 

 

8,773

 

 

 

3,303

 

U.S. government agency securities

 

 

4,898

 

 

 

 

 

 

(6

)

 

 

4,892

 

 

 

4,892

 

Commercial paper

 

 

1,633

 

 

 

34

 

 

 

 

 

 

1,667

 

 

 

 

Non-U.S. government securities

 

 

810

 

 

 

 

 

 

 

 

 

810

 

 

 

 

 

$

140,377

 

 

$

249

 

 

$

(8,170

)

 

$

132,456

 

 

$

87,538

 

Reported as follows:

 

 

Cost

 

 

Unrealized
Gain

 

 

Unrealized
(Loss)

 

 

Fair
Market
Value

 

 

Fair Market
Value of
Investments
with Unrealized
Losses

 

 

 

(in thousands)

 

Marketable securities

 

$

62,385

 

 

$

36

 

 

$

(267

)

 

 

62,154

 

 

$

34,844

 

Long-term marketable securities

 

 

77,992

 

 

 

213

 

 

 

(7,903

)

 

 

70,302

 

 

 

52,694

 

 

$

140,377

 

 

$

249

 

 

$

(8,170

)

 

$

132,456

 

 

$

87,538

 

12



   
Cost
   
Unrealized

Gain
   
Unrealized

(Loss)
  
Fair
Market

Value
   
Fair Market

Value of

Investments

with Unrealized

Losses
 
                    
   
(in thousands)
 
Marketable securities
  $39,950   $70   $(408 $39,612   $30,713 
Long-term marketable securities
   83,889    3    (10,633  73,259    69,050 
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
   $123,839   $73   $(11,041 $112,871   $99,763 
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 

As of July 2, 2023,March 31, 2024, the fair market value of investments with unrealized losses less than one year and greater than one year totaled $63.8$36.2 million and $58.8$41.4 million, respectively. As of December 31, 2022,2023, the fair market value of investments with unrealized losses for less than one year and greater than one year totaled $66.3$22.3 million and $33.4$65.2 million, respectively.

Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments at July 2, 2023March 31, 2024 and December 31, 20222023 were not other than temporary.

The contractual maturities of investments in

available-for-sale
securities held at July 2, 2023
,
March 31, 2024, were as follows:

 

 

March 31, 2024

 

 

 

Cost

 

 

Fair Market
Value

 

 

 

(in thousands)

 

Due within one year

 

$

41,308

 

 

$

41,300

 

Due after 1 year through 5 years

 

 

26,360

 

 

 

25,819

 

Due after 5 years through 10 years

 

 

7,760

 

 

 

7,405

 

Due after 10 years

 

 

37,094

 

 

 

29,445

 

Total

 

$

112,522

 

 

$

103,969

 

   
July 2, 2023
 
         
   
Cost
   
Fair Market

Value
 
         
   
(in thousands)
 
Due within one year
  $95,482   $95,199 
Due after 1 year through 5 years
   17,131    16,467 
Due after 5 years through 10 years
   6,012    5,559 
Due after 10 years
   38,236    31,221 
   
 
 
   
 
 
 
Total  $156,861   $148,446 
   
 
 
   
 
 
 

Contractual maturities of investments in

available-for-sale
securities held at July 2, 2023,March 31, 2024, exclude debt mutual funds with a fair market
value of $7.7$10.0 million as they do not have a contractual maturity date.

Derivatives

Teradyne conducts business in various foreign countries, with certain transactions denominated in local currencies. As a result, Teradyne is exposed to risks relating to changes in foreign currency exchange rates. Teradyne’s foreign currency risk management objective is to minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, and changes in its cash inflows attributable to the forecasted cash flows from certain foreign currency denominated revenues.

To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings and is used to offset the change in value of monetary assets and liabilities denominated in foreign currencies.

Teradyne also enters into foreign currency forward and option contracts designated as cash flow hedges to hedge the risk of changes in its cash inflows attributable to changes in foreign currency exchange rates. The cash flow hedges have maturities of less than six months and mature in the period of revenue recognition for certain products and services in backlog and forecasted to be recognized in a future period. Teradyne evaluates cash flow hedges for effectiveness at inception based on the critical terms match method. The hedges are not expected to incur any ineffectiveness however a quarterly qualitative assessment of effectiveness is done to determine if the critical terms match method remains appropriate to use. The change in fair value of the contracts is recorded in accumulated other comprehensive income (loss) and reclassified to earnings at maturity date.

Teradyne does not use derivative financial instruments for speculative purposes.

13


At July 2, 2023March 31, 2024 and December 31, 2022,2023, Teradyne had the following contracts to buy and sell

non-U.S.
currencies for U.S. dollars and other
non-U.S.
currencies with the following notional amounts:

 

 

Net Notional Value

 

 

 

March 31,
2024

 

 

December 31,
2023

 

 

 

(in millions)

 

Currency Hedged (Buy/Sell)

 

 

 

 

 

 

U.S. dollar/Japanese yen

 

$

57.5

 

 

$

11.0

 

U.S. dollar/Danish krone

 

 

28.4

 

 

 

36.0

 

U.S. dollar/Taiwan dollar

 

 

20.1

 

 

 

42.7

 

U.S. dollar/Korean won

 

 

6.6

 

 

 

7.2

 

U.S. dollar/British pound sterling

 

 

1.0

 

 

 

1.5

 

Euro/U.S. dollar

 

 

25.8

 

 

 

25.3

 

Singapore dollar/U.S. dollar

 

 

17.6

 

 

 

16.6

 

Philippine peso/U.S. dollar

 

 

9.9

 

 

 

10.1

 

Chinese yuan/U.S. dollar

 

 

0.6

 

 

 

1.0

 

Danish krone/U.S. dollar

 

 

0.6

 

 

 

0.7

 

Total

 

$

168.1

 

 

$

152.1

 


   
Net Notional Value
 
   
July 2, 2023
   
December 31, 2022
 
         
   
(in millions)
 
Currency Hedged (Buy/Sell)
  
U.S. dollar/Japanese yen $66.3   $37.1 
U.S. dollar/Taiwan dollar  22.3    29.2 
U.S. dollar/Korean won  8.1    6.4 
U.S. dollar/British pound sterling  0.9    1.2 
Euro/U.S. dollar  24.5    38.4 
Singapore dollar/U.S. dollar  22.0    34 
Philippine peso/U.S. dollar  2.5    2.7 
Chinese yuan/U.S. dollar  1.8    2.2 
Danish krone/U.S. dollar  0.6    —   
  
 
 
   
 
 
 
Total $149.0   $150.7 
  
 
 
   
 
 
 

The fair value of the outstanding contracts was a

gain
net loss of $1.1$0.1 million and
a net loss of
$0.9
1.8 million respectively, at July 2, 2023March 31, 2024 and December 31, 2022.
2023, respectively.

Unrealized gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net.

At July 2, 2023March 31, 2024 and December 31, 2022,2023, Teradyne had the following cash flow hedge contracts to buy and sell

non-U.S.
currencies for U.S. dollars with the following notional amounts:

 

 

Net Notional Value

 

 

 

March 31,
2024

 

 

December 31,
2023

 

 

 

(in millions)

 

Currency Hedged (Buy/Sell)

 

 

 

 

 

 

U.S. dollar/Japanese yen

 

$

 

 

$

35.5

 

Total

 

$

 

 

$

35.5

 


   
Net Notional Value
 
   
July 2, 2023
   
December 31, 2022
 
         
   
(in millions)
 
Currency Hedged (Buy/Sell)
  
Japanese yen/U.S. dollar  $52.8  $23.4 
Taiwan dollar/U.S. dollar       5.5 
U.S. dollar/Japanese yen   —      61.2 
U.S. dollar/Taiwan dollar   —      10.9 
   
 
 
   
 
 
 
Total  $52.8   $101.0 
   
 
 
   
 
 
 

There were no outstanding cash flow hedge contracts at March 31, 2024. The fair value of the outstanding cash flow hedge contracts was a gain of $3.7 million and a loss of $3.2$0.6 million at July 2, 2023 and December 31, 2022, respectively.

2023.

Unrealized gains and losses on foreign currency cash flow hedge contracts are included in accumulated other comprehensive income (loss). At maturity, the gains or losses associated with cash flow hedge contracts are recorded to revenue.

On November 7, 2023, in connection with our agreement to acquire 10% investment in Technoprobe S.p.A we purchased a call option to buy 481.0 million Euros. The expiration date of the option is April 26, 2024. On April 12, 2024, Teradyne entered into a forward to buy 481.0 million Euros expiring on May 23, 2024. At March 31, 2024 and December 31, 2023, the fair value of the outstanding contract was $3.4 million and $17.4 million, respectively. For the three months ended March 31, 2024, an unrealized loss of $13.9 million was recorded in other (income) expense, net.

14


The following table summarizes the fair value of derivative instruments as of July 2, 2023March 31, 2024 and December 31, 2022:2023:

 

 

Balance Sheet Location

 

March 31,
2024

 

 

December 31,
2023

 

 

 

 

 

(in thousands)

 

Derivatives not designated as hedging instruments:

 

Foreign exchange forward contracts

 

Other current assets

 

$

805

 

 

$

733

 

Foreign exchange option contracts

 

Other current assets

 

 

3,446

 

 

 

17,364

 

Foreign exchange forward contracts

 

Other current liabilities

 

 

(936

)

 

 

(2,545

)

Derivatives designated as hedging instruments:

 

Foreign exchange forward contracts

 

Other current assets

 

 

 

 

 

648

 

Total derivatives

 

 

 

$

3,315

 

 

$

16,200

 

   
Balance Sheet Location
  
July 2, 2023
   
December 31, 2022
 
            
      
(in thousands)
 
Derivatives not designated as hedging instruments:
      
Foreign exchange forward contracts
  Prepayments  $2,138   $86 
Foreign exchange forward contracts
  Other current liabilities   (994   (990
Derivatives designated as hedging instruments:
      
Foreign exchange forward contracts
  Prepayments   3,681    —   
Foreign exchange option contracts
  Other current liabilities   —      (3,225
    
 
 
   
 
 
 
Total derivatives
    $4,825   $(4,129
    
 
 
   
 
 
 
14

The following table summarizes the effect of derivative instruments recognized in the statement of operations for the three and six months ended JulyMarch 31, 2024 and April 2, 2023 and July 3, 2022:


2023:

 

 

 

 

For the Three Months
 Ended

 

 

 

Location of (Gains) Losses
Recognized in Statement
of Operations

 

March 31,
2024

 

 

April 2,
2023

 

 

 

 

 

(in thousands)

 

Derivatives not designated as hedging instruments:

 

Foreign exchange forward contracts (1)

 

Other (income) expense, net

 

$

(1,699

)

 

$

1,259

 

Foreign exchange option contracts

 

Other (income) expense, net

 

 

13,918

 

 

 

 

Derivatives designated as hedging instruments:

 

Foreign exchange forward and option contracts

 

Revenue

 

 

(2,280

)

 

 

1,538

 

Total Derivatives

 

 

 

$

9,939

 

 

$

2,797

 

(1)
      
For the Three Months

Ended
  
For the Six Months
Ended
 
   
Location of (Gains) Losses
Recognized in Statement of
Operations
  
July 2,
2023
  
July 3,
2022
  
July 2,
2023
  
July 3,
2022
 
                 
      
(in thousands)
    
Derivatives not designated as hedging instruments:
                    
Foreign exchange forward contracts
  
Other (income) expense, net
  $(4,040 $(1,703 $(2,781 $(3,455
Derivatives designated as hedging instruments:
                    
Foreign exchange option contracts
  
Revenue
   414   —     1,952   —   
      
 
 
  
 
 
  
 
 
  
 
 
 
Total Derivatives
     $(3,626 $(1,703 $(829 $(3,455
      
 
 
  
 
 
  
 
 
  
 
 
 
The table does not reflect the corresponding gains and losses from the remeasurement of the monetary assets and liabilities
denominated in foreign currencies. For the three and six months ended JulyMarch 31, 2024 and April 2, 2023, net losses from remeasurement of monetary assets and liabilities denominated in foreign currencies were $6.7$2.7 million and $7.0$0.4 million, respectively. For the three and six months ended July 3, 2022, net losses from remeasurement of monetary assets and liabilities denominated in foreign currencies were $3.7 million and $8.0 million, respectively.

See Note G:H: “Debt” regarding derivatives related to the convertible senior notes.

G.

H. DEBT

Convertible Senior Notes

On December 12, 2016, Teradyne completed a private offering of $460.0$460.0 million aggregate principal amount of 1.25%1.25% convertible senior unsecured notes (the “Notes”) due December 15, 2023 and received net proceeds, after issuance costs, of approximately $450.8$450.8 million, $33.0$33.0 million of which was used to pay the net cost of the convertible note hedge transactions and $50.1$50.1 million of which was used to repurchase 2.0 million shares of Teradyne’s common stock under its existing stock repurchase program from purchasers of the Notes in privately negotiated transactions effected through one of the initial purchasers or its affiliates conducted concurrently with the pricing of the Note offering. The Notes will mature on December 15, 2023, unless earlier repurchased or converted. The Notes bearbore interest at a rate of 1.25%1.25% per year payable semiannually in arrears on June 15 and December 15 of each year.year. The Notes will be convertible at the option of the noteholders at any time prior to the close of businessmatured on the business day immediately preceding SeptemberDecember 15, 2023 only under the following circumstances: (1) during any calendar quarter beginning after March 31, 2017 (and only during such calendar quarter), if the closing sale price of Teradyne’s common stock, for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the closing sale price of the Teradyne’s common stock and the conversion rate on each such trading day; and (3) upon the occurrence of specified corporate events. On or after September 15, 2023, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Notes at any time, regardless of the foregoing circumstances. Teradyne may satisfy its future conversion obligation by paying cash for the principal amount of the Notes and paying or delivering cash, shares of its common stock or a combination of cash and shares of its common stock, at Teradyne’s election for the amount in excess of principal. On November 4, 2021, Teradyne made an irrevocable election under the Indenture to require the principal portion of the remaining Notes to be settled in cash. As of July 2, 2023, the conversion price was approximately $31.43 per share of Teradyne’s common stock. The conversion rate is subject to adjustment under certain circumstances. As of August 4, 2023, one hundred and thirty-four debt holders had exercised the option to convert $436.1 million worth of notes.

.

Concurrent with the offering of the Notes, Teradyne entered into convertible note hedge transactions (the “Note Hedge Transactions”) with the initial purchasers or their affiliates (the “Option Counterparties”). The Note Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of the common stock that underlie the Notes, with a strike price equal to the conversion price of the Notes of $31.43.

Notes. Separately and concurrent with the pricing of the Notes, Teradyne entered into warrant transactions with the Option Counterparties (the “Warrant Transactions”) in which it sold
net-share-settled
(or, (or, at its election subject to certain conditions, cash-settled) warrants to the Option Counterparties. These transactions have been accounted for as an adjustment to our shareholders’ equity. The Warrant Transactions, which began expiring March 18, 2024 and will continue to expire through July 10, 2024, currently cover, subject to customary anti-dilution adjustments, approximately 14.613.8 million shares of common stock. During the three months ended March 31, 2024, 0.8 million warrants expired. As of July 2,
2023,March 31, 2024, the strike price of the warrants was approximately $39.44$39.37 per share. The strike price is subject to adjustment under certain circumstances. The Warrant Transactions could have a dilutive effect toresult in additional shares of Teradyne’s common stock being issued to the extent that the market price per share of Teradyne’s common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.

15


The Note Hedge Transactions are expected to reduce the potential dilution to Teradyne’s common stock upon any conversion of the Notes. However, the Warrant Transactions could separately have a dilutive effect to the extent that the market value per share of Teradyne’s common stock exceeds the applicable strike price of the warrant. The net cost of the Note Hedge Transactions, after being partially offset by the proceeds from the sale of the warrants, was approximately
$33.0 million.
In connection with establishing their initial hedge of these convertible note hedge and warrant transactions, the Option Counterparties have entered into various derivative transactions with respect to Teradyne’s common stock and/or purchased shares of Teradyne’s common stock or other securities, including the Notes, concurrent with, or shortly after, the pricing of the Notes. In addition, the Option Counterparties may modify their hedge positions by entering into or unwinding various derivative transactions with respect to Teradyne’s common stock or by selling Teradyne’s common stock or other securities, including the Notes, in secondary market transactions (and may do so during any observation period related to the conversion of the Notes). These activities could adversely affect the value of Teradyne’s common stock and the Notes.
Originally, Teradyne allocated $100.8 million of the $460.0 million principal amount of the Notes to the equity component, which represented a discount to the debt and was amortized to interest expense using the effective interest method through December 2023. Effective January 1, 2022, Teradyne adopted ASC
2020-06
using the modified retrospective method of transition and accounts for the debt as a single liability measured at its amortized cost. As a result of the adoption, Teradyne recorded an increase of $1.4 million to current debt for unsettled shares, an increase of $1.8 million to deferred tax assets, an increase of $6.6 million to long-term debt for unamortized debt discount, and an increase to retained earnings of $94.6 million for the reclassification of the equity component. Mezzanine equity representing unsettled shares value was reduced to zero and additional
paid-in
capital was reduced by $100.8 million.
Debt issuance fees at July 2, 2023, have been fully amortized to interest expense using the effective interest method over the seven-year term of the Notes.
The tables below represent the key components of Teradyne’s convertible senior notes:
   
July 2,

2023
   
December 31,
2022
 
         
   
(in thousands)
 
Debt principal
  $32,806   $50,228 
Unamortized debt issuance fees
   —      113 
   
 
 
   
 
 
 
Net
c
arrying amount of convertible debt
  $32,806   $50,115 
   
 
 
   
 
 
 
Teradyne’s convertible senior notes were reported as current debt at July 2, 2023 and December 31, 2022.

The interest expense on Teradyne’s convertibleTeradyne's senior notes for the three and six months ended JulyApril 2, 2023 and July 3, 2022 was as follows:

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

 

(in thousands)

 

Contractual interest expense on the coupon

 

$

 

 

$

138

 

Amortization of debt issuance fees recognized as interest expense

 

 

 

 

 

113

 

Total interest expense on the convertible debt

 

$

 

 

$

251

 

   
For the Three Months
Ended
   
For the Six Months

Ended
 
   
July 2,

2023
   
July 3,

2022
   
July 2,

2023
   
July 3,
2022
 
                 
   
(in thousands)
   
(in thousands)
 
Contractual interest expense on the coupon
  $100   $121   $238   $432 
Amortization of debt issuance fees recognized as interest expense
   —      64    113    130 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total interest expense on the convertible debt
  $100   $185   $351   $562 
   
 
 
   
 
 
   
 
 
   
 
 
 
As of July 2, 2023, the conversion price was approximately $31.43 per share and the if converted value of the notes was $116.2 million.
Additional conversions of approximately $8.9 million of debt principal will occur in the third quarter of 2023. Teradyne expects to make principal interest payments of $0.2 million in the next
12
months.
16

Revolving Credit Facility

On May 1, 2020, Teradyne entered into a credit agreement (the “Credit Agreement”) with Truist Bank, as administrative agent and collateral agent, and the lenders party thereto. The Credit Agreement provided for a three-year, senior secured revolving credit facility of $400.0$400.0 million (the “Credit Facility”).

On December 10, 2021, the Credit Agreement was amended to extend the maturity date of the Credit Facility to December 10, 2026. On October 5, 2022, the Credit Agreement was amended to increase the amount of the Credit Facility to $750.0$750.0 million from $400.0$400.0 million.

The Credit Agreement provides that, subject to customary conditions, Teradyne may seek to obtain from existing or new lenders the available incremental amount under the Credit Facility, not to exceed the greater of $200.0$200.0 million or 15%15% of consolidated EBIDTA. The interest rate applicable to loans under the Credit Facility are, at Teradyne’s option, equal to either a base rate plus a margin ranging from 0.00%0.00% to 0.75%0.75% per annum or SOFR plus a margin ranging from 1.10%1.10% to 1.85%1.85% per annum, based on the consolidated leverage ratio of Teradyne. In addition, Teradyne will pay a commitment fee on the unused portion of the commitments under the Credit Facility ranging from 0.15%0.15% to 0.25%0.25% per annum, based on the then applicable consolidated leverage ratio.

Teradyne is not required to repay any loans under the Credit Facility prior to maturity, subject to certain customary exceptions. Teradyne is permitted to prepay all or any portion of the loans under the Credit Facility prior to maturity without premium or penalty, other than customary SOFR breakage costs.

The Credit Agreement contains customary events of default, representations, warranties and affirmative and negative covenants that, among other things, limit Teradyne’s ability to sell assets, grant liens on assets, incur other secured indebtedness and make certain investments and restricted payments, all subject to exceptions set forth in the Credit Agreement. The Credit Agreement also requires Teradyne to satisfy two financial ratios measured as of the end of each fiscal quarter: a consolidated leverage ratio and an interest coverage ratio.

The Credit Facility is guaranteed by certain of Teradyne’s domestic subsidiaries and collateralized by assets of Teradyne and such subsidiaries, including a pledge of 65%65% of the capital stock of certain foreign subsidiaries.

As of August 4, 2023,May 3, 2024, the Credit Agreement was undrawn and Teradyne was in compliance with all covenants under the Credit Agreement.

I. PREPAYMENTS

H. PREPAYMENTS

Prepayments consist of the following:

 

 

March 31,
2024

 

 

December 31,
2023

 

 

 

(in thousands)

 

Contract manufacturer and supplier prepayments

 

$

491,512

 

 

$

502,257

 

Prepaid maintenance and other services

 

 

21,894

 

 

 

17,592

 

Prepaid taxes

 

 

14,335

 

 

 

16,083

 

Other prepayments

 

 

9,901

 

 

 

13,038

 

Total prepayments (1)

 

$

537,642

 

 

$

548,970

 

(1)
Excludes $3.2 million and $5.3 million at March 31, 2024 and December 31, 2023, respectively, of contract manufacturer and supplier prepayments, classified as assets held for sale. See Note E: “Assets held for sale” for additional information.


16

   
July 2,
2023
   
December 31,
2022
 
         
   
(in thousands)
 
Contract manufacturer and supplier prepayments
  $515,350   $491,105 
Prepaid maintenance and other services   15,557    14,545 
Prepaid taxes   15,437    18,625 
Other prepayments
   14,338    8,687 
   
 
 
   
 
 
 
Total prepayments
  $560,682   $532,962 
   
 
 
   
 
 
 

I.

J. PRODUCT WARRANTY

Teradyne generally provides a

one-year
warranty on its products, commencing upon installation, acceptance or shipment. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based on historical experience. Related costs are charged to the warranty accrual as incurred. The balance below is included in other accrued liabilities.

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

 

(in thousands)

 

Balance at beginning of period

 

$

15,698

 

 

$

14,181

 

Accruals for warranties issued during the period

 

 

3,259

 

 

 

4,117

 

Accruals related to pre-existing warranties

 

 

(683

)

 

 

(405

)

Settlements made during the period

 

 

(2,950

)

 

 

(4,992

)

Balance at end of period

 

$

15,324

 

 

$

12,901

 


   
For the Three Months

Ended
   
For the Six Months

Ended
 
   
July 2,
   
July 3,
   
July 2,
   
July 3,
 
   
2023
   
2022
   
2023
   
2022
 
                 
   
(in thousands)
 
Balance at beginning of period
  $12,901   $20,105   $14,181   $24,577 
Accruals for warranties issued during the period
   3,261    6,429    7,378    10,530 
Accruals related to
pre-existing
warranties
   (352   (1,611   (757   (4,370
Settlements made during the period
   (3,267   (8,887   (8,259   (14,701
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at end of period
  $12,543   $16,036   $12,543   $16,036 
   
 
 
   
 
 
   
 
 
   
 
 
 
17

When Teradyne receives revenue for extended warranties, beyond one year, it is deferred and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. The balance below is included in short and long-term deferred revenue and customer advances.

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

 

(in thousands)

 

Balance at beginning of period

 

$

34,897

 

 

$

56,180

 

Deferral of new extended warranty revenue

 

 

6,914

 

 

 

4,413

 

Recognition of extended warranty deferred revenue

 

 

(7,302

)

 

 

(11,250

)

Balance at end of period

 

$

34,509

 

 

$

49,343

 


   
For the Three Months

Ended
   
For the Six Months

Ended
 
   
July 2,
   
July 3,
   
July 2,
   
July 3,
 
   
2023
   
2022
   
2023
   
2022
 
                 
   
(in thousands)
 
Balance at beginning of period
  $49,343   $65,726   $56,180   $64,168 
Deferral of new extended warranty revenue
   4,467    9,788    8,881    21,563 
Recognition of extended warranty deferred revenue
   (9,388   (9,723   (20,639   (19,940
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at end of period
  $44,422   $65,791   $44,422   $65,791 
   
 
 
   
 
 
   
 
 
   
 
 
 
J.

K. STOCK-BASED COMPENSATION

On February 1, 2023 (the”Retirement(the “Retirement Date”), Mark E. Jagiela retired as Chief Executive Officer of Teradyne and a member of Teradyne’s Board of Directors, and Teradyne entered into an agreement (the “Retirement Agreement”) with Mr. Jagiela. Under the Retirement Agreement, Mr. Jagiela’s unvested time-based restricted stock units and stock options granted prior to his Retirement Date were modified to allow continued vesting; and any vested options or options that vest during that period may be exercised for the remainder of the applicable option term. During the sixthree months ended

July April 2, 2023, Teradyne recorded a stock-based compensation expense of $
5.9
million related to the Retirement Agreement.

Under Teradyne’s stock compensation plans, Teradyne grants time-based restricted stock units, performance-based restricted stock units and stock options, and employees are eligible to purchase Teradyne’s common stock through its Employee Stock Purchase Plan (“ESPP”).

Service-based restricted stock unit awards granted to employees vest in equal annual installments over four years.years. Restricted stock unit awards granted to

non-employee
directors vest after a
one-year
period, with 100%100% of the award vesting on the earlier of (a) the first anniversary of the grant date or (b) the date of the following year’s Annual Meeting of Shareholders. Teradyne expenses the cost of the restricted stock unit awards subject to time-based vesting, which is determined to be the fair market value of the shares at the date of grant, ratably over the period during which the restrictions lapse.

Performance-based restricted stock units (“PRSUs”) granted to Teradyne’s executive officers may have a performance metric based on relative total shareholder return (“TSR”). Teradyne’s three-year TSR performance is measured against the New York Stock Exchange (“NYSE”) Composite Index. The final number of TSR PRSUs that vest will vary based upon the level of performance achieved from 0%0% to 200%200% of the target shares. The TSR PRSUs will vest upon the three-year anniversary of the grant date. The TSR PRSUs are valued using a Monte Carlo simulation model. The number of units expected to be earned, based upon the achievement of the TSR market condition, is factored into the grant date Monte Carlo valuation. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized

17


during the year following the grant. Compensation expense is recognized regardless of the eventual number of units that are earned based upon the market condition, provided the executive officer remains an employee at the end of the three-year period. Compensation expense is reversed if at any time during the three-year service period the executive officer is no longer an employee, subject to the retirement and termination eligibility provisions noted below.

PRSUs granted to Teradyne’s executive officers may also have a performance metric based on three-year cumulative

non-GAAP
profit before interest and tax (“PBIT”) as a percent of Teradyne’s revenue.
Non-GAAP
PBIT is a financial measure equal to GAAP income from operations less restructuring and other, net; amortization of acquired intangible assets; acquisition and divestiture related charges or credits; pension actuarial gains and losses;
non-cash
convertible debt interest expense; and other
non-recurring
gains and charges. The final number of PBIT PRSUs that vest will vary based upon the level of performance achieved from 0%0% to 200%200% of the target shares. The PBIT PRSUs will vest upon the three-year anniversary of the grant date. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant date to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the year following the grant. Compensation expense is recognized based on the number of units that are earned based upon the three-year Teradyne PBIT as a percent of Teradyne’s revenue, provided the executive officer remains an employee at the end of the three-year period subject to the retirement and termination eligibility provisions noted below.
18

If a PRSU recipient’s employment ends prior to the determination of the performance percentage due to (1) permanent disability or death or (2) retirement or termination other than for cause, after attaining both at least age sixty and at least ten years of service, then all or a portion of the recipient’s PRSUs (based on the actual performance percentage achieved on the determination date) will

vest on the date the performance percentage is determined. Except as set forth in the preceding sentence, no PRSUs will vest if the executive officer is no longer an employee at the end of the three-year period. Stock options to purchase Teradyne’s common stock at 100%100% of the fair market value on the grant date vest in equal annual installments over four years from the grant date and have a maximum term of seven years
.

On January 22, 2024, the Board enacted the Executive Retirement Policy for Restricted Stock Unit and Option Vesting (the "Retirement Policy"). Under the Retirement Policy, an executive officer that is over the age of 65 and has 10 or more years of service as of the effective date of his or her retirement will be eligible for continued vesting of his or her unvested time-based restricted stock units and stock options granted prior to his or her retirement date.

During the sixthree months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, Teradyne granted 0.5 million and 0.40.5 million of service-based restricted stock unit awards to employees at a weighted average grant date fair value of $102.30$94.28 and $111.21, respectively, and $0.1 million of service-based restricted stock unit awards to

non-employee
directors at a weighted average grant date fair value of $90.50 and $106.91,$102.36, respectively.

During the sixthree months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, Teradyne granted 0.1 million and 0.1 million of PBIT PRSUs with a grant date fair value of $102.23$94.01 and $110.84,$102.23, respectively.

During the sixthree months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, Teradyne granted 0.1 million and 0.1 million of TSR PRSUs, with a grant date fair value of $137.64$100.87 and $101.06,$137.64, respectively. The fair value was estimated using the Monte Carlo simulation model with the following assumptions:

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

Risk-free interest rate

 

 

3.9

%

 

 

3.9

%

Teradyne volatility-historical

 

 

42.4

%

 

 

50.2

%

NYSE Composite Index volatility-historical

 

 

15.6

%

 

 

24.8

%

Dividend yield

 

 

0.5

%

 

 

0.4

%


   
For the Six Months

Ended
 
   
July 2,
  
July 3,
 
   
2023
  
2022
 
        
Risk-free interest rate
   3.9  1.4
Teradyne volatility-historical
   50.2  47.1
NYSE Composite Index volatility-historical
   24.8  22.7
Dividend yield
   0.4  0.4

Expected volatility was based on the historical volatility of Teradyne’s stock and the NYSE Composite Index over the most recent three-year period. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $0.44$0.48 per share divided by Teradyne’s stock price on the grant date of $103.44$95.14 for the 20232024 grant, and an estimated annual dividend amount of $0.44$0.44 per share divided by Teradyne’s stock price on the grant date of $112.12$103.44 for the 20222023 grant.

During the sixthree months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, Teradyne granted 0.1 million and 0.1 million of service-based stock options to executive officers at a weighted average grant date fair value of $40.90$37.50 and $39.01,$40.90, respectively.

18


The fair value of stock options was estimated using the Black-Scholes option-pricing model with the following assumptions:

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

Expected life (years)

 

 

4.0

 

 

 

4.0

 

Risk-free interest rate

 

 

4.0

%

 

 

3.7

%

Volatility-historical

 

 

46.3

%

 

 

46.7

%

Dividend yield

 

 

0.5

%

 

 

0.4

%


   
For the Six Months

Ended
 
   
July 2,
  
July 3,
 
   
2023
  
2022
 
        
Expected life (years)
   4.0   4.0 
Risk-free interest rate
   3.7  1.6
Volatility-historical
   46.7  43.7
Dividend yield
   0.4  0.4

Teradyne determined the stock options’ expected life based upon historical exercise data for executive officers, the age of the executive officers and the terms of the stock option grant. Volatility was determined using historical volatility for a period equal to the expected life. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $0.44$0.48 per share divided by Teradyne’s stock price on the grant date of $103.44$95.14 for the 20232024 grant and an estimated annual dividend amount of $0.44$0.44 per share divided by Teradyne’s stock price on the grant date of $112.12$103.44 for the 20222023 grant.

19

K.

L. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Changes in

a
ccumulated accumulated other comprehensive income (loss), which are presented net of tax, consist of the following:

 

 

Foreign
Currency
Translation
Adjustment

 

 

Unrealized
(Losses) Gains on
Marketable
Securities

 

 

Unrealized (Losses) Gains on Cash Flow Hedges

 

 

Retirement
Plans Prior
Service
Credit

 

 

Total

 

 

 

(in thousands)

 

Three Months Ended March 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2023, net of tax of $0, $(1,728),
  $
142, $(1,132), respectively

 

$

(22,442

)

 

$

(6,194

)

 

$

506

 

 

$

1,152

 

 

$

(26,978

)

Other comprehensive (loss) gain before reclassifications,
   net of tax of $
0, $(221), $358, $0, respectively

 

 

(11,457

)

 

 

(902

)

 

 

1,274

 

 

 

 

 

 

(11,085

)

Amounts reclassified from accumulated other comprehensive
  income (loss), net of tax of $
0, $30, $(500), $0, respectively

 

 

 

 

 

106

 

 

 

(1,780

)

 

 

(2

)

 

 

(1,676

)

Net current period other comprehensive loss, net of tax
  of $
0, $(191), $(142), $0, respectively

 

 

(11,457

)

 

 

(796

)

 

 

(506

)

 

 

(2

)

 

 

(12,761

)

Balance at March 31, 2024, net of tax of $0, $(1,919),
   $
0, $(1,132), respectively

 

$

(33,899

)

 

$

(6,990

)

 

$

 

 

$

1,150

 

 

$

(39,739

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended April 2, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2022, net of tax of $0, $(2,308),
   ($
708), $(1,130), respectively

 

$

(39,849

)

 

$

(8,661

)

 

$

(2,517

)

 

$

1,159

 

 

$

(49,868

)

Other comprehensive gain before reclassifications,
   net of tax of $
0, $503, $167, $0, respectively

 

 

9,309

 

 

 

2,294

 

 

 

596

 

 

 

 

 

 

12,199

 

Amounts reclassified from accumulated other comprehensive
  income (loss), net of tax of $
0, $2, $338, $0, respectively

 

 

 

 

 

5

 

 

 

1,200

 

 

 

(2

)

 

 

1,203

 

Net current period other comprehensive gain (loss), net of tax
  of $
0, $505, $505, $0, respectively

 

 

9,309

 

 

 

2,299

 

 

 

1,796

 

 

 

(2

)

 

 

13,402

 

Balance at April 2, 2023, net of tax of $0, $(1,803),
   $(
203), $(1,130), respectively

 

$

(30,540

)

 

$

(6,362

)

 

$

(721

)

 

$

1,157

 

 

$

(36,466

)


19


   
Foreign

Currency

Translation

Adjustment
  
Unrealized

(Losses)
Gains on

Marketable

Securities
  
Unrealized
(Losses)
Gains on
Cash Flow
Hedges
  
Retirement

Plans
Prior

Service

Credit
  
Total
 
                 
   
(in thousands)
 
Six Months Ended July 2, 2023
                     
Balance at December 31, 2022, net of tax of $0, $(2,308), $(708), $(1,130), respectively
  $(39,849 $(8,661 $(2,517 $1,159  $(49,868
Other comprehensive gain before reclassifications, net of tax of $0, $323, $1,088, $0, respectively
   12,250   1,726   3,866   —     17,842 
Amounts reclassified from accumulated other comprehensive income, net of tax of $0, $10, $428, $(1), respectively
   —     33   1,524   (3  1,554 
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Net current period other comprehensive gain (loss), net of tax of $0, $333, $1,516, $(1), respectively
   12,250   1,759   5,390   (3  19,396 
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance at July 2, 2023, net of tax of $0, $(1,975), $808, $(1,131), respectively
  $(27,599 $(6,902 $2,873  $1,156  $(30,472
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Six Months Ended July 3, 2022
                     
Balance at December 31, 2021, net of tax of $0, $1,055, $0, $(1,128), respectively
  $(10,818 $3,704  $—    $1,166  $(5,948
Other comprehensive loss before reclassifications, net of tax of $0, $(2,573), $0, $0, respectively
   (37,307  (9,910  —     —     (47,217
Amounts reclassified from accumulated other comprehensive income, net of tax of $0, $59, $0, $(1), respectively
   —     209   —     (3  206 
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Net current period other comprehensive loss, net of tax of $0, $(2,514), $0, $(1), respectively
   (37,307  (9,701  —     (3  (47,011
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance at July 3, 2022, net of tax of $0, $(1,459), $0, $(1,129), respectively
  $(48,125 $(5,997 $—    $1,163  $(52,959
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Reclas
sifica
tions

Reclassifications out of accumulated other comprehensive income (loss) to the statement of operations for the three and six months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, were as follows:


Details about Accumulated Other Comprehensive Income (Loss) Components

 

For the Three Months
 Ended

 

 

Affected Line Item
in the Statements
of Operations

 

 

March 31,
2024

 

 

April 2,
2023

 

 

 

 

 

(in thousands)

 

 

 

Available-for-sale marketable securities:

 

 

 

 

 

 

 

 

Unrealized losses, net of tax of $(30), $(2), respectively

 

$

(106

)

 

$

(5

)

 

Other (income) expense, net

Cash flow hedges:

 

 

 

 

 

 

 

 

Unrealized (losses) gains, net of tax of $500, $(338), respectively

 

 

1,780

 

 

 

(1,200

)

 

Revenue

Defined benefit pension and postretirement plans:

 

 

 

 

 

 

 

 

Amortization of prior service credit, net of tax of $0, $0,
   respectively

 

 

2

 

 

 

2

 

 

(a)

Total reclassifications, net of tax of $470, $(340), respectively

 

$

1,676

 

 

$

(1,203

)

 

Net income

(a)
Details about Accumulated Other Comprehensive Income (Loss) Components
  
For the Three Months
Ended
  
For the Six Months
Ended
  
Affected Line Item
in the Statements
of Operations
   
July 2,
  
July 3,
  
July 2,
  
July 3,
   
   
2023
  
2022
  
2023
  
2022
   
                
   
(in thousands)
   
Available-for-sale
marketable securities:
                   
Unrealized losses, net of tax of $(8), $(77), $(10), $(59), respectively
  $(28 $(274 $(33 $(209 Other (income) expense, net
Cash flow hedges:
                   
Unrealized losses, net of tax of $(91), $0, $(428), $0, respectively
   (323  —     (1,524  —    Revenue
Defined benefit pension and postretirement plans:
                   
Amortization of prior service credit, net of tax of $0, $0, $1, $1, respectively
   2   2   3   3  
(a)
   
 
 
  
 
 
  
 
 
  
 
 
   
Total reclassifications, net of tax of $(99), $(77), $(437), $(58), respectively
  $(349 $(272 $(1,554 $(206 
Net income
   
 
 
  
 
 
  
 
 
  
 
 
   
(a)
The amortization of prior service credit is included in the computation of net periodic postretirement benefit cost. See Note O:The amortization of prior service credit is included in the computation of net periodic postretirement benefit cost. See Note P: “Retirement Plans.”
20

L.

M. GOODWILL AND ACQUIRED INTANGIBLE ASSETS

Goodwill

Teradyne performs its annual goodwill impairment test as required under the provisions of ASC

350-10,
“Intangibles—Goodwill and Other”
on December 31 of each fiscal year unless interim indicators of impairment exist. In the sixthree months ended July 2, 2023,March 31, 2024, there were no interim indicators of impairment. Goodwill is considered impaired when the net book value of a reporting unit exceeds its estimated fair value.

The changes in the carrying amount of goodwill by reportable segments for the sixthree months ended July 2, 2023,March 31, 2024, were as follows:

 

 

Robotics

 

 

Wireless
Test

 

 

Semiconductor
Test

 

 

System
Test

 

 

Total

 

 

 

(in thousands)

 

Balance at December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

$

395,463

 

 

$

361,819

 

 

$

262,237

 

 

$

158,699

 

 

$

1,178,218

 

Accumulated impairment losses

 

 

 

 

 

(353,843

)

 

 

(260,540

)

 

 

(148,183

)

 

 

(762,566

)

Total Goodwill

 

 

395,463

 

 

 

7,976

 

 

 

1,697

 

 

 

10,516

 

 

 

415,652

 

Foreign currency translation adjustment

 

 

(7,962

)

 

 

 

 

 

(114

)

 

 

 

 

 

(8,076

)

Balance at March 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

$

387,502

 

 

$

361,819

 

 

$

262,123

 

 

$

158,699

 

 

 

1,170,142

 

Accumulated impairment losses

 

 

 

 

 

(353,843

)

 

 

(260,540

)

 

 

(148,183

)

 

 

(762,566

)

Total Goodwill

 

$

387,502

 

 

$

7,976

 

 

$

1,583

 

 

$

10,516

 

 

$

407,576

 


20


   
Robotics
   
Wireless
Test
  
Semiconductor
Test
  
System Test
  
Total
 
                  
   
(in thousands)
 
Balance at December 31, 2022
                      
Goodwill
  $383,166   $361,819  $262,077  $158,699  $1,165,761 
Accumulated impairment losses
   —      (353,843  (260,540  (148,183  (762,566
   
 
 
   
 
 
  
 
 
  
 
 
  
 
 
 
Total Goodwill
   383,166    7,976   1,537   10,516   403,195 
   
 
 
   
 
 
  
 
 
  
 
 
  
 
 
 
Foreign currency translation adjustment
   8,857    —     58   —     8,915 
   
 
 
   
 
 
  
 
 
  
 
 
  
 
 
 
Balance at July 2, 2023
                      
Goodwill
   392,023    361,819   262,135   158,699   1,174,676 
Accumulated impairment losses
   —      (353,843  (260,540  (148,183  (762,566
   
 
 
   
 
 
  
 
 
  
 
 
  
 
 
 
Total Goodwill
  $392,023   $7,976  $1,595  $10,516  $412,110 
   
 
 
   
 
 
  
 
 
  
 
 
  
 
 
 

Intangible Assets

Teradyne reviews long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate.

Amortizable intangible assets consist of the following and are included in intangible assets, net on the balance sheet:

 

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization

 

 

Foreign
Currency
Translation
Adjustment

 

 

Net
Carrying
Amount

 

 

 

(in thousands)

 

Balance at March 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

$

267,706

 

 

$

(246,266

)

 

$

(5,635

)

 

$

15,805

 

Customer relationships

 

 

52,109

 

 

 

(48,278

)

 

 

203

 

 

 

4,034

 

Tradenames and trademarks

 

 

59,007

 

 

 

(47,231

)

 

 

(1,381

)

 

 

10,395

 

Total intangible assets

 

$

378,822

 

 

$

(341,775

)

 

$

(6,813

)

 

$

30,234

 

Balance at December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

$

267,706

 

 

$

(243,191

)

 

$

(5,343

)

 

$

19,172

 

Customer relationships

 

 

52,109

 

 

 

(47,850

)

 

 

232

 

 

 

4,491

 

Tradenames and trademarks

 

 

59,007

 

 

 

(46,021

)

 

 

(1,245

)

 

 

11,741

 

Total intangible assets

 

$

378,822

 

 

$

(337,062

)

 

$

(6,356

)

 

$

35,404

 



   
Gross

Carrying

Amount (1)
   
Accumulated

Amortization (1)
   
Foreign
Currency
Translation
Adjustment
   
Net

Carrying

Amount
 
                 
   
(in thousands)
 
Balance at July 2, 2023
     
Developed technology
  $267,708   $(237,078  $(5,444  $25,186 
Customer relationships
   52,109    (46,699   200    5,610 
Tradenames and trademarks
   59,007    (43,904   (1,288   13,815 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total intangible assets
  $378,824   $(327,681  $(6,532  $44,611 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance, December 31, 2022
                    
Developed technology
  $270,967   $(234,208  $(5,935  $30,824 
Customer relationships
   57,739    (51,186   172    6,725 
Tradenames and trademarks
   59,387    (41,930   (1,528   15,929 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total intangible assets
  $388,093   $(327,324  $(7,291  $53,478 
   
 
 
   
 
 
   
 
 
   
 
 
 
(1)
In 2023, $9.3 million of amortizable intangible assets became fully amortized and have been eliminated from the gross carrying amount and accumulated amortization.

Aggregate intangible asset amortization expense was $4.8$4.7 million and $9.6$4.8 million, respectively, for the three and six months ended JulyMarch 31, 2024 and April 2, 20232023.

,
and $4.9 million and $9.9 million, respectively
,
for the three and six months ended July 3, 2022.
21

Estimated intangible asset amortization expense for each of the five succeeding fiscal years and thereafter is as follows:

Year

 

Amortization
Expense

 

 

 

(in thousands)

 

2024

 

$

14,010

 

2025

 

 

11,290

 

2026

 

 

2,364

 

2027

 

 

1,148

 

2028

 

 

1,066

 

Thereafter

 

 

356

 

Year
  
Amortization Expense
 
   
(in thousands)
 
2023
  $9,443 
2024
   18,834 
2025
   11,352 
2026
   2,379 
2027
   1,162 
Thereafter
   1,441 
M.

N. NET INCOME PER COMMON SHARE

The following table sets forth the computation of basic and diluted net income per common share:

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

 

(in thousands, except per share amounts)

 

Net income for basic and diluted net income per share

 

$

64,197

 

 

$

83,531

 

Weighted average common shares-basic

 

 

153,047

 

 

 

155,904

 

Effect of dilutive potential common shares:

 

 

 

 

 

 

Convertible note hedge warrant shares (1)

 

 

8,862

 

 

 

8,983

 

Incremental shares from assumed conversion of convertible notes (2)

 

 

 

 

 

914

 

Restricted stock units

 

 

419

 

 

 

453

 

Stock options

 

 

16

 

 

 

48

 

Employee stock purchase plan

 

 

4

 

 

 

6

 

Dilutive potential common shares

 

 

9,301

 

 

 

10,404

 

Weighted average common shares-diluted

 

 

162,348

 

 

 

166,308

 

Net income per common share-basic

 

$

0.42

 

 

$

0.54

 

Net income per common share-diluted

 

$

0.40

 

 

$

0.50

 

21


(1)
Convertible notes hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price, multiplied by the number of warrant shares. The result of this calculation, representing the total intrinsic value of the warrant, was divided by the average Teradyne stock price for the period.
(2)
Incremental shares from assumed conversion of the convertible notes were calculated using the difference between the average Teradyne stock price for the period and the conversion price, multiplied by the number of convertible notes shares. The result of this calculation, representing the total intrinsic value of the convertible notes, was divided by the average Teradyne stock price for the period.
   
For the Three Months

Ended
   
For the Six Months

Ended
 
   
July 2,
   
July 3,
   
July 2,
   
July 3,
 
   
2023
   
2022
   
2023
   
2022
 
                 
   
(in thousands, except per share amounts)
 
Net income for basic and diluted net income per share
  $120,050   $197,787   $203,581   $359,715 
   
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average common shares-basic
   154,760    159,563    155,332    160,805 
Effect of dilutive potential common shares:
                    
Convertible note hedge warrant shares (1)
   8,876    9,029    8,929    9,528 
Incremental shares from assumed conversion of convertible notes (2)
   742    1,900    828    2,220 
Restricted stock units
   323    581    389    730 
Stock options
   43    54    45    61 
Employee stock purchase plan
   7    32    7    23 
   
 
 
   
 
 
   
 
 
   
 
 
 
Dilutive potential common shares
   9,991    11,596    10,198    12,562 
   
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average common shares-diluted
   164,751    171,159    165,530    173,367 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net income per common share-basic
  $0.78   $1.24   $1.31   $2.24 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net income per common share-diluted
  $0.73   $1.16   $1.23   $2.07 
   
 
 
   
 
 
   
 
 
   
 
 
 
(1)
Convertible notes hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price, multiplied by the number of warrant shares. The result of this calculation, representing the total intrinsic value of the warrant, was divided by the average Teradyne stock price for the period.
(2)
Incremental shares from assumed conversion of the convertible notes were calculated using the difference between the average Teradyne stock price for the period and the conversion price, multiplied by the number of convertible notes shares. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period.

The computation of diluted net income per common share for the three and six months ended JulyMarch 31, 2024 and April 2, 2023,

,
excludes the effect of the potential vesting of 0.4 million and 0.5 million, respectively, of restricted stock units because the effect would have been anti-dilutive.

The computation of diluted net income per common share for the three and six months ended July 3, 2022
,
excludes the effect of the potential vesting of 0.1 million and 0.2 million, respectively, of restricted stock units because the effect would have been anti-dilutive.
N.

O. RESTRUCTURING AND OTHER

During the three months ended July 2, 2023,March 31, 2024, Teradyne recorded $5.1$2.2 million of acquisition and divestiture expenses related to the Technoprobe transaction, and $2.0 million of severance charges related to headcount reductions of 112 people primarily in Robotics and Semiconductor Test, and Robotics

which included charges related to a voluntary early retirement program for employees meeting certain conditions 
and a charge of $1.1 million for an increase in environmental liability.
conditions.

During the three months ended July 3, 2022,April 2, 2023, Teradyne recorded a charge of $1.5 million for an increase in environmental and legal liabilities.


22

During the six months ended July 2, 2023, Teradyne recorded $
7.2
2.0 million of severance charges related to headcount reductions of 1
79
 people primarily in Semiconductor Test, Robotics, and Robotics
 which included charges related to a voluntary early retirement program for employees meeting certain conditions
and a charge of $
1.1
 million for an increase in environmental liability.

Corporate.

During the six months ended July 3, 2022, Teradyne recorded a charge of $14.7 million related to the arbitration claim filed against Teradyne and AutoGuide related to an
earn-out
dispute, which was settled on March 25, 2022 for $26.7 million, and a charge of $2.0 million for an increase in environmental and legal liabilities.
O.

P. RETIREMENT PLANS

ASC 715, “Compensation—Retirement Benefits,” requires an employer with defined benefit plans or other postretirement benefit plans to recognize an asset or a liability on its balance sheet for the overfunded or underfunded status of the plans as defined by ASC 715. The pension asset or liability represents a difference between the fair value of the pension plan’s assets and the projected benefit obligation at December 31. Teradyne uses a December 31 measurement date for all its plans.

Defined Benefit Pension Plans

Teradyne has defined benefit pension plans covering a portion of domestic employees and employees of certain

non-U.S.
subsidiaries. Benefits under these plans are based on employees’ years of service and compensation. Teradyne’s funding policy is to make contributions to these plans in accordance with local laws and to the extent that such contributions are tax deductible. The assets of the U.S. qu
alifie
dqualified pension plan consist primarily of fixed income and equity securities. In addition, Teradyne has an unfunded supplemental executive def
ined b
enefitdefined benefit plan in the United States to provide retirement benefits in excess of levels allowed by the Employment Retirement Income Security Act (“ERISA”) and the Internal Revenue Code (the “IRC”), as well as unfunded qualified foreign plans.

In the sixthree months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, Teradyne contributed $1.5$0.8 million and $1.6$0.8 million, respectively, to the U.S. supplemental executive defined benefit pension plan, and $0.6$0.3 million and $0.5$0.2 million, respectively, to certain qualified pension plans for non-U.S. subsidiaries.

non-U.S.
subsidiaries.

For the three and six months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, Teradyne’s net periodic pension cost was comprised of the following:

 

 

For the Three Months Ended

 

 

 

March 31, 2024

 

 

April 2, 2023

 

 

 

United
States

 

 

Foreign

 

 

United
States

 

 

Foreign

 

 

 

(in thousands)

 

Service cost

 

$

231

 

 

$

117

 

 

$

272

 

 

$

109

 

Interest cost

 

 

1,647

 

 

 

246

 

 

 

1,711

 

 

 

262

 

Expected return on plan assets

 

 

(1,268

)

 

 

(16

)

 

 

(1,285

)

 

 

(9

)

Total net periodic pension cost

 

$

610

 

 

$

347

 

 

$

698

 

 

$

362

 


22


   
For the Three Months Ended
 
                 
   
July 2, 2023
   
July 3, 2022
 
   
United

States
   
Foreign
   
United

States
   
Foreign
 
                 
   
(in thousands)
 
Service cost
  $272   $110   $397   $180 
Interest cost
   1,714    263    1,221    120 
Expected return on plan assets
   (1,286   (9   (732   (18
Net actuarial loss (gain)
   24    —      (45   —   
   
 
 
   
 
 
   
 
 
   
 
 
 
Total net periodic pension cost
  $724   $364   $841   $282 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
   
For the Six Months Ended
 
                 
   
July 2, 2023
   
July 3, 2022
 
   
United

States
   
Foreign
   
United

States
   
Foreign
 
                 
   
(in thousands)
 
Service cost
  $543   $220   $794   $386 
Interest cost
   3,425    526    2,443    238 
Expected return on plan assets
   (2,571   (18   (1,463   (38
Net actuarial loss (gain)
   24    —      (45   —   
   
 
 
   
 
 
   
 
 
   
 
 
 
Total net periodic pension cost
  $1,421   $728   $1,729   $586 
   
 
 
   
 
 
   
 
 
   
 
 
 

Postretirement Benefit Plan

In addition to receiving pension benefits, Teradyne employees in the United States who meet early retirement eligibility requirements as of their termination dates may participate in Teradyne’s Welfare Plan, which includes medical and dental benefits up to age 65. Death benefits provide a fixed sum to retirees’ survivors and are available to all retirees. Substantially all of Teradyne’s current U.S. employees could become eligible for these benefits and the existing benefit obligation relates primarily to those employees.

During the three and six months ended July 2, 2023,March 31, 2024, Teradyne recorded special termination benefit charges associated with a voluntary early retirement program.

23

For the three and six months ended JulyMarch 31, 2024 and April 2, 2023, and July 3, 2022, Teradyne’s net periodic postretirement benefit cost was comprised of the following:


 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

 

(in thousands)

 

Service cost

 

$

10

 

 

$

9

 

Interest cost

 

 

73

 

 

 

61

 

Amortization of prior service credit

 

 

(2

)

 

 

(2

)

Special termination benefits

 

 

292

 

 

 

 

Total net periodic postretirement benefit cost

 

$

373

 

 

$

68

 

   
For the Three Months

Ended
   
For the Six Months

Ended
 
                 
   
July 2,
2023
   
July 3,
2022
   
July 2,
2023
   
July 3,
2022
 
                 
   
(in thousands)
 
Service cost
  $8   $15   $17   $32 
Interest cost
   60    45    121    88 
Amortization of prior service credit
   (2   (2   (4   (4
Special termination benefits
   369    —      369    —   
Net actuarial loss
   30    54    30    54 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total net periodic postretirement benefit cost
  $465   $112   $533   $170 
   
 
 
   
 
 
   
 
 
   
 
 
 

P.

Q. COMMITMENTS AND CONTINGENCIES

Purchase Commitments

As of July 2, 2023,March 31, 2024, Teradyne had entered into purchase commitments for certain components and materials. The purchase commitments covered by the agreements aggregate to approximately $554.5$428.8 million, of which $482.4$404.7 million is for less than one year.

Legal Claims

Teradyne is subject to various legal proceedings and claims which have arisen in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. Teradyne believes that it has meritorious defenses against all pending claims and intends to vigorously contest them. While it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, Teradyne believes the potential losses associated with all of these actions are unlikely to have a material adverse effect on its business, financial position or results of operations.

On March 8, 2021, Industrial Automation LLC, sellers of AutoGuide, submitted a demand for arbitration against Teradyne and AutoGuide in Wilmington, Delaware alleging that Teradyne and AutoGuide breached certain provisions of the Membership Interests Purchase Agreement (the “Purchase Agreement”), dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide. The arbitration demand sought full acceleration of the maximum
earn-out
amount payable under the Purchase Agreement, or $106.9 million, for the alleged breach of the
earn-out
provisions of the Purchase Agreement. On March 25, 2022, the arbitration claim was settled for $26.7 million. As a result, Teradyne has no remaining
earn-out
obligations.

Guarantees and Indemnification Obligations

Teradyne provides indemnification, to the extent permitted by law, to its officers, directors, employees and agents for liabilities arising from certain events or occurrences, while the officer, director, employee, or agent, is or was serving, at Teradyne’s request in

such capacity. Teradyne may enter into indemnification agreements with certain of its officers and directors. With respect to acquisitions, Teradyne provides indemnifications to or assumes indemnification obligations for the current and former directors, officers and employees of the acquired companies in accordance with the acquired companies’
by-laws
and charter. As a matter of practice, Teradyne has maintained directors’ and officers’ liability insurance coverage including coverage for directors and officers of acquired companies.

Teradyne enters into agreements in the ordinary course of business with customers, resellers, distributors, integrators and suppliers. Most of these agreements require Teradyne to defend and/or indemnify the other party against intellectual property infringement claims brought by a third party with respect to Teradyne’s products. From time to time, Teradyne also indemnifies customers and business partners for damages, losses and liabilities they may suffer or incur relating to personal injury, personal property damage, product liability, breach of confidentiality obligations and environmental claims relating to the use of Teradyne’s products and services or resulting from the acts or omissions of Teradyne, its employees, authorized agents or subcontractors. On occasion, Teradyne has also provided guarantees to customers regarding the delivery and performance of its products in addition to the warranty described below.

As a matter of ordinary course of business, Teradyne warrants that its products will substantially perform in accordance with its standard published specifications in effect at the time of delivery. Most warranties have a

one-year
duration commencing from

23


installation. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based upon historical experience. When Teradyne receives revenue for extended warranties beyond the standard duration, the revenue is deferred

24

and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. As of July 2, 2023March 31, 2024 and December 31, 2022,2023, Teradyne had a product warranty accrual of $12.5$15.3 million and $14.2$15.7 million, respectively, included in other accrued liabilities and revenue deferrals related to extended warranties of $44.4$34.5 million and $56.2$34.9 million, respectively, included in short and long-term deferred revenue and customer advances.

In addition, in the ordinary course of business, Teradyne provides minimum purchase guarantees to certain vendors to ensure continuity of supply against the market demand. Although some of these guarantees provide penalties for cancellations and/or modifications to the purchase commitments as the market demand decreases, most of the guarantees do not. Therefore, as the market demand decreases, Teradyne

re-evaluates
these guarantees and determines what charges, if any, should be recorded.

With respect to its agreements covering product, business or entity divestitures and acquisitions, Teradyne provides certain representations, warranties and covenants to purchasers and agrees to indemnify and hold such purchasers harmless against breaches of such representations, warranties and covenants. Many of the indemnification claims have a definite expiration date while some remain in force indefinitely. With respect to its acquisitions, Teradyne may, from time to time, assume the liability for certain events or occurrences that took place prior to the date of acquisition.

As a matter of ordinary course of business, Teradyne occasionally guarantees certain indebtedness obligations of its subsidiary companies, limited to the borrowings from financial institutions, purchase commitments to certain vendors and lease commitments to landlords.

Based on historical experience and information known as of July 2, 2023March 31, 2024 and December 31, 2022,2023, except for product warranty, Teradyne has not recorded any liabilities for these guarantees and obligations because the amount would be immaterial.

Q.

R. INCOME TAXES

A reconciliation of the United States federal statutory corporate tax rate to Teradyne’s effective tax rate was as follows:

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

U.S. statutory federal tax rate

 

 

21.0

%

 

 

21.0

%

Tax credits

 

 

(3.1

)

 

 

(2.5

)

Discrete benefit related to reserves for uncertain tax positions

 

 

(3.1

)

 

 

 

International provisions of the U.S. Tax Cuts and Jobs Act of 2017

 

 

(2.2

)

 

 

(3.2

)

Foreign taxes

 

 

(2.1

)

 

 

(0.6

)

Discrete benefit related to equity compensation

 

 

(0.9

)

 

 

(3.3

)

Other, net

 

 

2.3

 

 

 

2.6

 

Effective tax rate

 

 

11.9

%

 

 

14.0

%


   
For the Three Months

Ended
  
For the Six Months

Ended
 
              
   
July 2,
2023
  
July 3,
2022
  
July 2,
2023
  
July 3,
2022
 
U.S. statutory federal tax rate
   21.0  21.0  21.0  21.0
Discrete expense related to foreign currency gain/loss   1.2   0.6   0.7   0.6 
Non-deductible
officers’ compensation
   1.0   1.4   1.0   1.3 
International provisions of the U.S. Tax Cuts and Jobs Act of 2017
   (2.5  (1.0  (2.8  (1.2
Tax credits
   (2.4  (2.0  (2.4  (1.8
Discrete benefit related to equity compensation
   (0.1  (0.2  (1.4  (2.9
Foreign taxes
   (1.0  (3.2  (0.8  (3.3
Other, net
   (0.3  0.5   0.4   0.4 
   
 
 
  
 
 
  
 
 
  
 
 
 
Effective tax rate
   16.9  17.1  15.7  14.1
   
 
 
  
 
 
  
 
 
  
 
 
 

On a quarterly basis, Teradyne evaluates the realizability of the deferred tax assets by jurisdiction and assesses the need for a valuation allowance. As of July 2, 2023,March 31, 2024, Teradyne believes that it will ultimately realize the deferred tax assets recorded on the condensed consolidated balance sheet. However, should Teradyne believe that it is

more-likely-than-not
that the deferred tax assets would not be realized, the tax provision would increase in the period in which Teradyne determined that the realizability was not likely. Teradyne considers the probability of future taxable income and historical profitability, among other factors, in assessing the realizability of the deferred tax assets.

As of July 2, 2023March 31, 2024 and December 31, 2022,2023, Teradyne had $15.9$15.9 million and $15.6$18.6 million, respectively, of reserves for uncertain tax positions. The $0.3$2.7 million net increasedecrease in reserves for uncertain tax positions is related to U.S. federal research and development credits generated in the current year.

settlement of an audit.

As of July 2, 2023,March 31, 2024, Teradyne estimates that it is reasonably possible that the balance of unrecognized tax benefits may decrease approximately $0.1$0.8 million in the next twelve months because of a lapse of statutes of limitation. The estimated decrease relates to U.S. federal and state research and development credits.

Teradyne recognizes interest and penalties related to income tax matters in income tax expense. As of July 2, 2023March 31, 2024 and December 31, 2022, $0.52023, $0.7 million and $0.4$1.3 million, respectively, of interest and penalties were accrued for uncertain tax positions. For the sixthree months ended JulyMarch 31, 2024 and April 2, 2023, benefit of $0.6 million and July 3, 2022, an expense of $0.1 million and $0.1$0.1 million, respectively, was recorded for interest and penalties related to income tax items.


25

24


Teradyne qualifies for a tax holiday in Singapore by fulfilling the requirements of an agreement with the Singapore Economic Development Board under which certain headcount and spending requirements must be met. The tax savings due to the tax holiday for the sixthree months ended July 2, 2023,March 31, 2024, was

$
1.0
1.1 million, or $
0.01
per diluted share. The tax savings due to the tax holiday for the sixthree months ended July 3, 2022
,
April 2, 2023, was $
8.3
0.2 million, or $
0.05
0.0per diluted share. In November 2020, Teradyne entered into an agreement with the Singapore Economic Development Board which extended our Singapore tax holiday under substantially similar terms to the agreement which expired on December 31, 2020. The new tax holiday is scheduled to expire on December 31, 2025.

On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into law. The IRA introduced a 15%15% alternative minimum tax based on the financial statement income of certain large corporations (“CAMT”), effective January 1, 2023. Teradyne currently does not expect the CAMT to have a material impact on its financial results.

On December 15, 2022, the European Union ("EU") Member States formally adopted the EU’s Pillar Two Directive, which generally provides for a minimum effective tax rate of 15%, as established by the Organization for Economic Co-operation and Development ("OECD") Pillar Two Framework. The EU’s Pillar Two Directive effective dates are January 1, 2024, and January 1, 2025, for different aspects of the directive. On July 17, 2023, the OECD published Administrative Guidance proposing certain safe harbor rules that effectively extend certain effective dates to January 1, 2027. Certain EU Member States where Teradyne has a legal presence have recently enacted the directive and administrative guidance into their local tax legislation. Additionally, countries outside the EU where Teradyne has a legal presence have enacted similar language as the EU Members States in their local tax legislation. Teradyne is closely monitoring these developments and evaluating the potential financial impact on income tax expense. As of March 31, 2024, Teradyne anticipates it will meet the safe harbors in most jurisdictions, and any remaining tax under the rules should be immaterial for the year ending December 31, 2024.

R.

S. SEGMENT INFORMATION

Teradyne has four reportable segments (Semiconductor Test, System Test, Wireless Test and Robotics). Each of the reportable segments represents an individual operating segment.

The Semiconductor Test segment includes operations related to the design, manufacturing and marketing of semiconductor test products and services. The System Test segment includes operations related to the design, manufacturing and marketing of products and services for defense/aerospace instrumentation test, storage and system level test, defense/aerospace instrumentation test, and circuit-board test. The Wireless Test segment includes operations related to the design, manufacturing and marketing of wireless test products and services. The Robotics segment includes operations related to the design, manufacturing and marketing of collaborative robotic arms, autonomous mobile robots and advanced robotic control software. Each operating segment has a segment manager who is accountable to and maintains regular contactcontract with Teradyne’s chief operating decision maker (Teradyne’s chief executive officer) to discuss operating activities, financial results, forecasts, and plans for the segment.

Teradyne evaluates performance based on several factors, of which the primary financial measure is business segment income (loss) before income taxes. The accounting policies of the business segments are the same as those described in Note B: “Accounting Policies” in Teradyne’s Annual Report on Form

10-K
for the year ended December 31, 2022.
2023.

Segment information for the three and six months ended JulyMarch 31, 2024 and April 2, 2023 and July 3, 2022 is as follows:


 

 

Semiconductor
Test

 

 

System
Test

 

 

Robotics

 

 

Wireless
Test

 

 

Segment Total

 

 

Corporate
and
Eliminations

 

 

Consolidated

 

 

 

(in thousands)

 

Three Months Ended March 31, 2024

 

Revenues

 

$

412,254

 

 

$

75,322

 

 

$

87,654

 

 

$

24,589

 

 

$

599,819

 

 

$

 

 

$

599,819

 

Income (loss) before income taxes (1)(2)

 

 

79,414

 

 

 

18,391

 

 

 

(14,047

)

 

 

(893

)

 

$

82,865

 

 

 

(9,963

)

 

$

72,902

 

Total assets (3)

 

 

1,348,829

 

 

 

181,803

 

 

 

721,318

 

 

 

69,519

 

 

$

2,321,469

 

 

 

1,089,251

 

 

$

3,410,720

 

Three Months Ended April 2, 2023

 

Revenues

 

$

415,009

 

 

$

74,631

 

 

$

89,214

 

 

$

38,675

 

 

$

617,529

 

 

$

 

 

$

617,529

 

Income (loss) before income taxes (1)(2)

 

 

96,185

 

 

 

15,275

 

 

 

(18,490

)

 

 

9,352

 

 

$

102,322

 

 

 

(5,238

)

 

$

97,084

 

Total assets (3)

 

 

1,386,851

 

 

 

173,669

 

 

 

676,092

 

 

 

87,875

 

 

$

2,324,487

 

 

 

1,058,920

 

 

$

3,383,407

 

   
Semiconductor

Test
   
System

Test
   
Robotics
  
Wireless

Test
   
Corporate

and

Eliminations
  
Consolidated
 
                       
   
(in thousands)
 
Three Months Ended July 2, 2023
                            
Revenues
  $474,708   $94,272   $71,634  $43,823   $—    $684,437 
Income (loss) before income taxes (1)(2)
   129,040    28,599    (26,401  12,020    1,144   144,402 
Total assets (3)
   1,416,109    191,002    685,132   88,869    1,013,784   3,394,896 
Three Months Ended July 3, 2022
                            
Revenues
  $541,348   $134,702   $101,055  $63,854   $(193 $840,766 
Income (loss) before income taxes (1)(2)
   177,782    54,042    (6,406  25,393    (12,219  238,592 
Total assets (3)
   1,449,878    229,359    644,099   118,445    1,046,645   3,488,426 
Six Months Ended July 2, 2023
                            
Revenues
  $889,717   $168,903   $160,848  $82,498   $—    $1,301,966 
Income (loss) before income taxes (1)(2)
   225,225    43,874    (44,891  21,372    (4,094  241,486 
Total assets (3)
   1,416,109    191,002    685,132   88,869    1,013,784   3,394,896 
Six Months Ended July 3, 2022
                            
Revenues
  $1,023,688   $253,371   $204,244  $115,372   $(539 $1,596,136 
Income (loss) before income taxes (1)(2)
   327,487    95,365    (11,504  44,012    (36,409  418,951 
Total assets (3)
   1,449,878    229,359    644,099   118,445    1,046,645   3,488,426 
(1)
(1)
Included in Corporate and Eliminations are: interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, legal and environmental fees, severance charges, pension, acquisition and divestiture related fees, and an expense for the modification of Teradyne’s former chief executive officer’s outstanding equity awards.
(2)
Included in income (loss) before taxes are charges related to restructuring and other, and inventory charges.
(3)
Total assets are attributable to each segment. Corporate assets consist of cash and cash equivalents, marketable securities, and certain other assets.
(2)
Included in income (loss) before taxes are charges related to restructuring and other, expense for the modification of outstanding equity awards, and inventory charges.

25


26(3)
Total assets are attributable to each segment. Semiconductor Test includes $33.9 million of total assets classified as assets held for sale. See Note E: "Assets held for sale" for additional information. Corporate assets consist of cash and cash equivalents, marketable securities, and certain other assets.

Included in each segment are charges and credits in the following line items in the statements of operations:


 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

 

(in thousands)

 

Semiconductor Test:

 

 

 

 

 

 

Cost of revenues—inventory charge

 

$

4,956

 

 

$

3,768

 

Restructuring and other—employee severance

 

 

983

 

 

 

794

 

System Test:

 

 

 

 

 

 

Cost of revenues—inventory charge

 

$

 

 

$

675

 

Robotics:

 

 

 

 

 

 

Cost of revenues—inventory charge

 

$

 

 

$

782

 

Corporate and Eliminations:

 

 

 

 

 

 

Restructuring and other—acquisition & divestiture related expenses

 

 

2,214

 

 

 

 

Selling and administrative —equity modification

 

 

1,469

 

 

 

5,889

 

Restructuring and other—employee severance

 

$

 

 

$

659

 

   
For the Three Months

Ended
   
For the Six Months

Ended
 
                 
   
July 2,
2023
   
July 3,
2022
   
July 2,
2023
   
July 3,
2022
 
                 
   
(in thousands)
 
Semiconductor Test:
                    
Cost of revenues—inventory charge
  $4,184   $2,071   $7,952   $2,315 
Restructuring and other—employee severance
   2,485    —      3,279      
System Test:
                    
Cost of revenues—inventory charge
  $—     $—     $1,113   $—   
Restructuring and other—employee severance
   —      —      642    —   
Robotics:
                    
Restructuring and other—employee severance
  $1,638   $—     $2,071   $—   
Cost of revenues—inventory charge
   769    831    1,551    1,197 
Wireless:
                    
Cost of revenues—inventory charge
  $—     $2,099   $725   $2,976 
Corporate and Eliminations:
                    
Restructuring and other—other
  $1,100    1,500    1,100    2,000 
Restructuring and other—employee severance
   —      —      1,124    —   
Selling and administrative—equity modification charge
   —      —      5,889    —   
Restructuring and other—legal settlement charge
   —      —      —      14,700 

S.

T. SHAREHOLDERS’ EQUITY

Stock Repurchase Program

In January 2023, Teradyne’s Board of Directors cancelled its January 2021 repurchase program and approved a new repurchase program for up to $2.0$2.0 billion of common stock. Teradyne intends to repurchase up to $500.0 million of its common stock in 2023 based on market conditions.

During the six months ended July 2, 2023, Teradyne repurchased 2.2 million shares of common stock for a total cost of $229.5 million at an average price of $102.35 per share. As of January 1, 2023, share repurchases in excess of issuances are subject to a 1%1% excise tax, which is i
n
cluded
included as
part of the cost basis of the shares acquired.
Teradyne intends to repurchase up to $90.0 million of its common stock in 2024 based on market conditions.

During the sixthree months ended July 3, 2022,March 31, 2024, Teradyne repurchased 5.00.2 million shares of common stock for $532.8a total cost of $22.1 million at an average price of $107.50$100.31 per share.

The cumulative repurchases under the January 2023 repurchase program as of March 31, 2024 were 4.1 million shares of common stock for $422.6 million at an average price per share of $102.35.

During the three months ended April 2, 2023, Teradyne repurchased 0.9 million shares of common stock for $93.7 million at an average price of $104.88 per share.

The total cost of shares acquired includes commissions and starting in 2023, related excise tax, and is recorded as a reduction to retained earnings.

Dividend

Holders of Teradyne’s common stock are entitled to receive dividends when they are declared by Teradyne’s Board of Directors.

In January 20232024 and MayJanuary 2023, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.11$0.12 per share.share and $0.11 per share, respectively. Dividend payments for the three and six months ended JulyMarch 31, 2024 and April 2, 2023,

,
were $17.0$18.4 million and $34.2$17.2 million, respectively.

In January 2022 and May 2022, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.11 per share. Dividend payments for the three and six months ended July 3, 2022
,
were $17.5 million and $35.4 million, respectively.
27

26


Item 2:
Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations

Statements in this Quarterly Report on Form

10-Q
which are not historical facts, so called “forward-looking statements,” are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those detailed in our filings with the Securities and Exchange Commission. See also Part II, Item 1A of this Quarterly Report on Form
10-Q
and Part I, Item 1A “Risk Factors” in our Annual Report on Form
10-K
for the year ended December 31, 2022.2023. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.

Overview

We are a leading global supplier of automated test equipment and robotics solutions.products. We design, develop, manufacture and sell automatic test systems and robotics products. Our automatic test systems are used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including the consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Our robotics products include collaborative robotic arms and autonomous mobile robots (“AMRs”) used by global manufacturing, logistics and industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Our automatic test equipment and robotics products and services include:

semiconductor test (“Semiconductor Test”) systems;
storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”);
wireless test (“Wireless Test”) systems; and
robotics (“Robotics”) products.

The market for our test products is concentrated with a limited number of significant customers accounting for a substantial portion of the purchases of test equipment. A few customers drive significant demand for our test products both through direct sales and sales to the customers’ supply partners. We expect that sales of our test products will continue to be concentrated with a limited number of significant customers for the foreseeable future.

In the first quarter of 2024, artificial intelligence applications (“AI”) drove Semiconductor Test performance above our plan, particularly in Memory. We expect AI to continue to drive meaningful demand into the second quarter of 2023, the2024, helping to offset weak demand in our Semiconductor Test business continued to be impacted by a correction cycle driven by excess semiconductor inventory, primarilythe smartphone mobility test market. We anticipate an upturn in the mobility, segment of the market. The depth of this slowdown and the timing of the recovery are uncertain, however, strong automotive demand and in Memory test, the growth of DDR5 and High Bandwidth Memory (“HBM”) devices for data center applications are partially offsetting these declines. Over the midterm we expect the ramp of 3 nanometer and gate-all-around process technology, increasing multichip packaging, additional device complexity and unit growth will drive additional demand for test.

which may not materialize until 2025.

Our Robotics segment consists of Universal Robots A/S (“UR”), a leading supplier of collaborative robotic arms, and Mobile Industrial Robots A/S (“MiR”), a leading maker of AMRs for industrial automation. The market for our Robotics segment products is dependent on the adoption of new automation technologies by large manufacturers as well as small and medium enterprises (“SMEs”) throughout the world. InRobotics results in the first quarter of 2024 were in line with our forecast, putting us in position for full year growth due to new product offerings, expansion of our Original Equipment Manufacturer (“OEM”) and large account channels, along with increasing recurring revenue via service and software offerings.

On November 7, 2023, Teradyne and Technoprobe S.p.A, (“Technoprobe”), a leader in the design and production of probe cards, announced the establishment of a strategic partnership that will seek to accelerate growth for both companies and enable higher performance semiconductor test interfaces for customers worldwide. As part of the partnership, Teradyne agreed to make an investment of 481.0 million Euros in exchange for a 10% equity investment in Technoprobe, and Technoprobe agreed to acquire 100% of Teradyne’s Device Interface Solutions ("DIS") business in exchange for $85.0 million. The transaction is expected to close during the second quarter of 2023, Robotics demand has softened significantly due2024, subject to slowing global industrial activity and macro-economic headwinds.

In the second quarter of 2023, we met customer demand, in part, through faster than expected recoveries from supply chain constraints, while inflation had minimal effects on our results. Both our test and robotics businesses may still be influenced by supply constraints during the remainder of 2023, which could impact our revenue and costs. For example, our third quarter 2023 forecast excludes approximately $35 million of revenue, primarily in our test businesses, due to these continued supply chain constraints.
regulatory approval.

Our financial statements are denominated in U.S. dollars. While the majority of our revenues are in U.S. dollars, historically approximately 70 percent of our Robotics revenue is denominated in foreign currencies. In 2022, the strengthening of the U.S. dollar was a factor in lower than forecasted revenues in our Robotics segment. Strengthening of the U.S. dollar would negatively affect Robotics revenue growth in 2023.

2024.

28

27


Our corporate strategy continues to focus on profitably gaining market share in our test businesses through the introduction of differentiated products that target expanding segments and accelerating growth through continued investment in our Robotics businesses. We plan to execute on our strategy while balancing capital allocations between returning capital to our shareholders through stock repurchases and dividends and using capital for opportunistic accretive acquisitions.

Impact of the
COVID-19
Pandemic on our Business
The novel coronavirus
(COVID-19)
pandemic resulted in government authorities implementing numerous measures in an effort to contain the spread of the virus, such as travel bans and restrictions, limitations on gatherings or social distancing requirements, quarantines,
shelter-in-place
orders, vaccination and testing mandates, and business limitations and shutdowns. These measures impacted our
day-to-day
operations and disrupted our business, workforce and operations, as well as the operations of our customers, contract manufacturers and suppliers. In the second quarter of 2023 the
COVID-19
pandemic had significantly less impact on our business than in prior quarters since the start of the pandemic in 2020. However, we are unable to accurately predict the future impact of
COVID-19,
which will depend on future developments that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, any new surges or new strains or variants of the virus in areas where we do business.
Due to the
COVID-19
pandemic, there has been uncertainty and disruption in the global economy and our markets. We are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of August 4, 2023, the date of issuance of this Quarterly Report on Form
10-Q.
We believe the
COVID-19
pandemic and the numerous measures implemented by authorities in response, adversely impacted our results of operations, including by increasing costs, but we cannot accurately estimate the amount of the impact to our financial results. In addition, the pandemic disrupted our contract manufacturers and suppliers, and resulted in supply constraints and in short-term cost increases to meet customer demand.
Supply Chain Constraints and Inflationary Pressures
The global supply shortage of electrical components, including semiconductor chips, continued to impact our supply chain in the second quarter of 2023. We are seeing improvements related to supply constraints however, we experienced, and expect to continue to experience through the remainder of 2023, increases in our lead times and costs for certain components for certain of our products. In addition, while not material, inflationary pressures contributed to increased costs for product components and wage inflation, impacting our cost of products, gross margin and profit for the quarter. Our supply chain team, and our suppliers, continue to manage numerous supply, production, and logistics obstacles. While not material through the second quarter of 2023, in an effort to mitigate these risks, in some cases, we have incurred higher costs due to investment in supply chain resiliency and to secure available inventory or have extended or placed
non-cancellable
purchase commitments with semiconductor suppliers, which introduces inventory risk if our forecasts and assumptions prove inaccurate. We have also sourced components from additional suppliers and multi-sourced and
pre-ordered
components and finished goods inventory in some cases in an effort to reduce the impact of the adverse supply chain conditions we have experienced. There is no assurance that these efforts will be successful. Our third quarter 2023 forecast excludes approximately $35 million of revenue, primarily in our test businesses, due to these continued supply chain constraints.
See Part II—Item 1A, “Risk Factors,” included in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2022 for our risk factors regarding risks associated with both the
COVID-19
pandemic and international conflicts.

Critical Accounting Policies and Estimates

We have identified the policies which are critical to understanding our business and our results of operations. There have been no significant changes during the sixthree months ended July 2, 2023,March 31, 2024, to the items disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form

10-K
for the fiscal year ended December 31, 2022,2023, except as noted below.

Critical accounting estimates are complex and may require significant judgment by management. Changes to the underlying assumptions may have a material impact on our financial condition and results of operations. These estimates may change, as new events occur and additional information is obtained. Actual results could differ significantly from these estimates under different assumptions or conditions.

Preparation of Financial Statements and Use of Estimates

The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts reported in the financial statements. Actual results may differ significantly from these estimates under different assumptions or conditions.

29

SELECTED RELATIONSHIPS WITHIN THE CONDENSED CONSOLIDATED

STATEMENTS OF OPERATIONS

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

Percentage of revenues:

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

Products

 

 

76

%

 

 

77

%

Services

 

 

24

 

 

 

23

 

Total revenues

 

 

100

 

 

 

100

 

Cost of revenues:

 

 

 

 

 

 

Cost of products

 

 

33

 

 

 

32

 

Cost of services

 

 

10

 

 

 

10

 

Total cost of revenues (exclusive of acquired intangible
   assets amortization shown separately below)

 

 

43

 

 

 

42

 

Gross profit

 

 

57

 

 

 

58

 

Operating expenses:

 

 

 

 

 

 

Selling and administrative

 

 

25

 

 

 

24

 

Engineering and development

 

 

17

 

 

 

17

 

Acquired intangible assets amortization

 

 

1

 

 

 

1

 

Restructuring and other

 

 

1

 

 

 

 

Total operating expenses

 

 

44

 

 

 

43

 

Income from operations

 

 

13

 

 

 

15

 

Non-operating (income) expense:

 

 

 

 

 

 

Interest income

 

 

(1

)

 

 

(1

)

Interest expense

 

 

 

 

 

 

Other (income) expense, net

 

 

2

 

 

 

 

Income before income taxes

 

 

12

 

 

 

16

 

Income tax provision

 

 

1

 

 

 

2

 

Net income

 

 

11

%

 

 

14

%

28


   
For the Three Months

Ended
  
For the Six Months

Ended
 
        
   
July 2,
  
July 3,
  
July 2,
  
July 3,
 
   
2023
  
2022
  
2023
  
2022
 
              
Percentage of revenues:
                 
Revenues:
                 
Products
   79  83  78  83
Services
   21   17   22   17 
   
 
 
  
 
 
  
 
 
  
 
 
 
Total revenues
   100   100   100   100 
Cost of revenues:
                 
Cost of products
   32   33   32   32 
Cost of services
   9   7   10   7 
   
 
 
  
 
 
  
 
 
  
 
 
 
Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below)
   41   40   42   40 
   
 
 
  
 
 
  
 
 
  
 
 
 
Gross profit
   59   60   58   60 
Operating expenses:
                 
Selling and administrative
   21   17   23   18 
Engineering and development
   15   13   16   14 
Acquired intangible assets amortization
   1   —     1   1 
Restructuring and other
   1   —     1   1 
   
 
 
  
 
 
  
 
 
  
 
 
 
Total operating expenses
   38   31   40   33 
   
 
 
  
 
 
  
 
 
  
 
 
 
Income from operations
   20   29   18   27 
Non-operating
(income) expense:
                 
Interest income
   (1  —     (1  —   
Interest expense
   —     —     —     —   
Other (income) expense, net
   —     1   —     1 
   
 
 
  
 
 
  
 
 
  
 
 
 
Income before income taxes
   21   28   19   26 
Income tax provision
   4   5   3   4 
   
 
 
  
 
 
  
 
 
  
 
 
 
Net income
   18  24  16  23
   
 
 
  
 
 
  
 
 
  
 
 
 

Results of Operations

Second

First Quarter 20232024 Compared to SecondFirst Quarter 2022

2023

Revenues

Revenues by our reportable segments were as follows:

   
For the Three Months

Ended
     
   
July 2,
   
July 3,
   
Dollar
 
   
2023
   
2022
   
Change
 
             
   
(in millions)
 
Semiconductor Test
  $474.7   $541.3   $(66.6
System Test
   94.3    134.7    (40.4
Robotics
   71.6    101.1    (29.5
Wireless Test
   43.8    63.9    (20.1
Corporate and Eliminations
   —      (0.2   0.2 
   
 
 
   
 
 
   
 
 
 
   $684.4   $840.8   $(156.4
   
 
 
   
 
 
   
 
 
 

 

 

For the Three Months
 Ended

 

 

 

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

Dollar
Change

 

 

 

(in millions)

 

Semiconductor Test

 

$

412.3

 

 

$

415.0

 

 

$

(2.7

)

System Test

 

 

75.3

 

 

 

74.6

 

 

 

0.7

 

Robotics

 

 

87.7

 

 

 

89.2

 

 

 

(1.5

)

Wireless Test

 

 

24.6

 

 

 

38.7

 

 

 

(14.1

)

 

$

599.8

 

 

$

617.5

 

 

$

(17.7

)

The decrease in Semiconductor Test revenues of $66.6$2.7 million, or 12.3%0.7%, was driven primarily by lower tester sales for Mobilityautomotive applications, partially offset by higher Memory testTest sales in Flash Final Test.DRAM wafer sort. The decreaseincrease in System Test revenues of $40.4$0.7 million, or 30.0%0.9%, was primarily due to higher sales in Defense/Aerospace, partially offset by lower sales in Storage Test of system level and hard disk drive testers, partially offset by higher sales in Defense/Aerospace. The decrease in Robotics revenues of $29.5 million, or 29.2%, was driven primarily by softening demand due to slowing global industrial activity and macro-economic headwinds and the impact of the transformation of Universal Robots distribution channel.testers. The decrease in Wireless Test revenues of $20.1$14.1 million, or 31.5%,36.4% was primarily due to a decrease in connectivity and ultra wide band test products.

30

Revenues by country as a percentage of total revenues were as follows (1):

 

 

For the Three Months
 Ended

 

 

 

March 31,
2024

 

 

April 2,
2023

 

Korea

 

 

28

%

 

 

12

%

United States

 

 

17

 

 

 

18

 

Taiwan

 

 

12

 

 

 

18

 

Japan

 

 

11

 

 

 

9

 

Europe

 

 

11

 

 

 

12

 

China

 

 

7

 

 

 

10

 

Singapore

 

 

3

 

 

 

8

 

Malaysia

 

 

3

 

 

 

3

 

Philippines

 

 

2

 

 

 

5

 

Thailand

 

 

2

 

 

 

3

 

Rest of World

 

 

4

 

 

 

2

 

 

 

 

100

%

 

 

100

%

(1)
Revenues attributable to a country are based on location of customer site.
   
For the Three Months

Ended
 
   
July 2,
  
July 3,
 
   
2023
  
2022
 
        
United States
   17  14
Korea
   15   17 
Taiwan
   15   25 
China
   13   13 
Japan
   13   5 
Europe
   9   8 
Malaysia
   5   5 
Thailand
   4   6 
Philippines
   4   3 
Singapore
   3   2 
Rest of World
   2   2 
   
 
 
  
 
 
 
    100  100
   
 
 
  
 
 
 
(1)
Revenues attributable to a country are based on location of customer site.

Gross Profit

Our gross profit was as follows:

                                              
   
For the Three Months

Ended
    
   
July 2,
  
July 3,
  
Dollar/Point
 
   
2023
  
2022
  
Change
 
           
   
(in millions)
 
Gross profit
  $402.5  $506.4  $(103.9
Percent of total revenues
   58.8  60.2  (1.4

 

 

For the Three Months
 Ended

 

 

 

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

Dollar/Point
Change

 

 

 

(in millions)

 

Gross profit

 

$

339.3

 

 

$

356.4

 

 

$

(17.1

)

Percent of total revenues

 

 

56.6

%

 

 

57.7

%

 

 

(1.2

)

Gross profit as a percent of revenue decreased by 1.41.2 points, primarily due to product mix and lower volume.

29


Selling and Administrative

Selling and administrative expenses were as follows:

                                              
   
For the Three Months

Ended
    
   
July 2,
  
July 3,
  
Dollar
 
   
2023
  
2022
  
Change
 
           
   
(in millions)
 
Selling and administrative
  $145.7  $139.5  $6.2 
Percent of total revenues
   21.3  16.6    

 

 

For the Three Months
 Ended

 

 

 

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

Dollar
Change

 

 

 

(in millions)

 

Selling and administrative

 

$

149.2

 

 

$

151.0

 

 

$

(1.8

)

Percent of total revenues

 

 

24.9

%

 

 

24.4

%

 

 

 

The increasedecrease of $6.2$1.8 million in selling and administrative expenses was primarily due to lower spending in Robotics, partially offset by higher variable compensation.

31

spending in Semiconductor Test.

Engineering and Development

Engineering and development expenses were as follows:

                                                                
   
For the Three Months

Ended
    
   
July 2,
  
July 3,
  
Dollar
 
   
2023
  
2022
  
Change
 
           
   
(in millions)
 
Engineering and development
  $105.7  $112.0  $(6.3
Percent of total revenues
   15.4  13.3    

 

 

For the Three Months
 Ended

 

 

 

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

Dollar
Change

 

 

 

(in millions)

 

Engineering and development

 

$

103.2

 

 

$

105.8

 

 

$

(2.6

)

Percent of total revenues

 

 

17.2

%

 

 

17.1

%

 

 

 

The decrease of $6.3$2.6 million in engineering and development expenses was primarily due to lower spending in Semiconductor Test, partially offset by higher spending in Robotics.

Restructuring and Other

During the three months ended July 2, 2023,March 31, 2024, we recorded $5.1$2.2 million of acquisition and divestiture related costs and $2.0 million of severance charges related to headcount reductions of 112 people primarily in Semiconductor Test and Robotics which included charges related to a voluntary early retirement program for employees meeting certain conditions and a charge of $1.1 million for an increase in environmental liability.

Robotics.

During the three months ended July 3, 2022,April 2, 2023, we recorded a charge$2.0 million of $1.5 million for an increaseseverance charges related to headcount reduction primarily in environmentalSemiconductor Test, Robotics and legal liabilities.

Corporate.

Interest and Other

   
                        
   
                        
   
                        
 
   
For the Three Months

Ended
     
   
July 2,
   
July 3,
   
Dollar
 
   
2023
   
2022
   
Change
 
             
   
(in millions)
 
Interest income
  $(6.4  $(1.0  $(5.4
Interest expense
   1.0    0.9   $0.1 
Other (income) expense, net
   0.8    9.4   $(8.6
Interest income

 

 

For the Three Months
 Ended

 

 

 

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

Dollar
Change

 

 

 

(in millions)

 

Interest income

 

$

(7.9

)

 

$

(5.3

)

 

$

(2.6

)

Interest expense

 

 

0.7

 

 

 

1.0

 

 

$

(0.3

)

Other (income) expense, net

 

 

12.1

 

 

 

0.1

 

 

$

12.0

 

Other (income) expense, net increased by $5.4$12.0 million primarily due to higher interest ratesthe change in 2023. Other (income) expense, net decreased by $8.6 million primarily due to changesvalue of our call option purchased in unrealized gains/losses on equity securities, from a $6.6 million loss in 2022 to a $2.6 million gain in 2023.connection with the anticipated acquisition of Technoprobe.

30


Income (Loss) Before Income Taxes

 

 

For the Three Months
 Ended

 

 

 

 

 

 

March 31,
2024

 

 

April 2,
2023

 

 

Dollar
Change

 

 

 

(in millions)

 

Semiconductor Test

 

$

79.4

 

 

$

96.2

 

 

$

(16.8

)

System Test

 

 

18.4

 

 

 

15.3

 

 

 

3.1

 

Wireless Test

 

 

(0.9

)

 

 

9.4

 

 

 

(10.3

)

Robotics

 

 

(14.0

)

 

 

(18.5

)

 

 

4.5

 

Corporate and Eliminations (1)

 

 

(10.0

)

 

 

(5.2

)

 

 

(4.8

)

 

$

72.9

 

 

$

97.1

 

 

$

(24.2

)

(1)
Included in Corporate and Eliminations are: interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, severance charges, pension, acquisition and divestiture related fees, and an expense for the modification of outstanding equity awards
   
                        
   
                        
   
                        
 
   
For the Three Months

Ended
     
   
July 2,
   
July 3,
   
Dollar
 
   
2023
   
2022
   
Change
 
             
   
(in millions)
 
Semiconductor Test
  $129.0   $177.8   $(48.8
System Test
   28.6    54.0    (25.4
Wireless Test
   12.0    25.4    (13.4
Robotics
   (26.4   (6.4   (20.0
Corporate and Eliminations (1)
   1.1    (12.2   13.3 
   
 
 
   
 
 
   
 
 
 
   $144.4   $238.6   $(94.2
   
 
 
   
 
 
   
 
 
 
(1)
Included in Corporate and Eliminations are interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, legal and environmental fees, and severance charges.

The decrease in income before income taxes in Semiconductor Test was driven primarily by lower tester sales for Mobility applications, partially offset by higher Memory test sales in Flash Final Test. The decrease in income before income taxes in System Test was primarilymargins due to lowerproduct mix as well as higher operating expenses on similar sales in Storage Test of system level and hard disk drive testers.levels. The decrease in income before income taxes in Wireless Test was driven primarily bydue to a decrease in sales of connectivity and ultra wide band test products. The decreaseincrease in income before income taxes in Robotics was driven primarily by softening demand due to slowing global industrial activity and macro-economic headwinds and the impact of the transformation of Universal Robots distribution channel.lower operating expenses on similar sales. The incomeloss before income taxes in Corporate and Eliminations was primarily due to changes in unrealized gains/losses on equity securities.

32

securities and the call option related to our anticipated investment in Technoprobe.

Income Taxes

The effective tax rate for the three months ended JulyMarch 31, 2024 and April 2, 2023, was 11.9% and July 3, 2022, was 16.9% and 17.1%14.0%, respectively. The decrease in the effective tax rate from the three months ended July 3, 2022,April 2, 2023, to the three months ended July 2, 2023,March 31, 2024, primarily resulted from an increase inthe benefit from the international provisions of the U.S. Tax Cuts and Jobs Act of 2017, a reduction in

non-deductible
officers’ compensation uncertain tax positions and an increase inthe benefit related to tax credits. These reductions in expense were partially offset byof a projected shift in the geographic distribution of income, which increases the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions and an increase in discrete expense related to foreign currency gain or loss.
Six Months 2023 Compared to Six Months 2022
Revenues
Revenues by our reportable segmentsincome. These benefits were as follows:
                                                                                  
   
For the Six Months

Ended
     
   
July 2,
   
July 3,
   
Dollar
 
   
2023
   
2022
   
Change
 
             
   
(in millions)
 
Semiconductor Test
  $889.7   $1,023.7   $(134.0
System Test
   168.9    253.4    (84.5
Robotics
   160.8    204.2    (43.4
Wireless Test
   82.5    115.4    (32.9
Corporate and Eliminations
   —      (0.5   0.5 
   
 
 
   
 
 
   
 
 
 
   $1,302.0   $1,596.1   $(294.1
   
 
 
   
 
 
   
 
 
 
The decrease in Semiconductor Test revenues of $134.0 million, or 13.1%, was driven primarily by lower tester sales for Mobility and Compute applications, partially offset by higher Memory test sales in Flash Final Test. The decrease in System Test revenues of $84.5 million, or 33.3%, was primarily due to lower sales in Storage Test of system level and hard disk drive testers. The decrease in Robotics revenues of $43.4 million, or 21.3%, was driven primarily by softening demand due to slowing global industrial activity and macro-economic headwinds and the impact of the transformation of Universal Robots distribution channel. The decrease in Wireless Test revenues of $32.9 million, or 28.5%, was primarily due to a decrease in sales of connectivity test products.
Revenues by country as a percentage of total revenues were as follows (1):
   
For the Six Months

Ended
 
   
July 2,
  
July 3,
 
   
2023
  
2022
 
        
United States
   17  15
Taiwan
   16   22 
Korea
   14   15 
China
   12   16 
Japan
   11   5 
Europe
   10   9 
Singapore
   5   3 
Philippines
   5   3 
Malaysia
   4   5 
Thailand
   3   5 
Rest of World
   3   2 
   
 
 
  
 
 
 
    100  100
   
 
 
  
 
 
 
(1)
Revenues attributable to a country are based on location of customer site.
33

Gross Profit
Our gross profit was as follows:
   
                        
   
                        
   
                        
 
   
For the Six Months

Ended
    
   
July 2,
  
July 3,
  
Dollar/Point
 
   
2023
  
2022
  
Change
 
           
   
(in millions)
 
Gross profit
  $758.9  $961.3  $(202.4
Percent of total revenues
   58.3  60.2  (1.9
Gross profit as a percent of revenue decreased by 1.9 points, primarily due to a lower volume.
Selling and Administrative
Selling and administrative expenses were as follows:
   
                        
   
                        
   
                        
 
   
For the Six Months

Ended
    
   
July 2,
  
July 3,
  
Dollar
 
   
2023
  
2022
  
Change
 
           
   
(in millions)
 
Selling and administrative
  $296.7  $279.7  $17.0 
Percent of total revenues
   22.8  17.5    
The increase of $17.0 million in selling and administrative expenses was primarily due to the charge of $5.9 million recorded in the six months ended July 2, 2023, related to the modification of Teradyne’s chief executive officer’s outstanding equity awards in connection with his retirement and higher spending in System Test, Semiconductor Test and Robotics.
Engineering and Development
Engineering and development expenses were as follows:
   
                        
   
                        
   
                        
 
   
For the Six Months

Ended
    
   
July 2,
  
July 3,
  
Dollar
 
   
2023
  
2022
  
Change
 
           
   
(in millions)
 
Engineering and development
  $211.5  $220.1  $(8.6
Percent of total revenues
   16.2  13.8    
The decrease of $8.6 million in engineering and development expenses was due to lower variable compensation and lower spending in Semiconductor Test, partially offset by higher spending in Robotics.
Restructuring and Other
During the six months ended July 2, 2023, we recorded $7.2 million of severance charges related to headcount reductions of 179 people primarily in Semiconductor Test and Robotics which included charges related to a voluntary early retirement program for employees meeting certain conditions and a charge of $1.1 million for an increase in environmental liability.
During the six months ended July 3, 2022, we recorded a charge of $14.7 million related to the arbitration claim filed against Teradyne and AutoGuide related to an
earn-out
dispute, which was settled on March 25, 2022 for $26.7 million, and a charge of $2.0 million for an increase in environmental and legal liabilities.
34

Interest and Other
   
                              
   
                              
   
                              
 
   
For the Six Months

Ended
     
   
July 2,
   
July 3,
   
Dollar
 
   
2023
   
2022
   
Change
 
             
   
(in millions)
 
Interest income
  $(11.6  $(1.7  $(9.9
Interest expense
   2.0    1.9    0.1 
Other (income) expense, net
   0.9    14.6    (13.7
Interest income increased by $9.9 million primarily due to higher interest rates in 2023. Other (income) expense, net decreased by $13.7 million primarily due to changes in unrealized gains/losses on equity securities, from an $8.8 million loss in 2022 to a $4.6 million gain in 2023.
Income (Loss) Before Income Taxes
                                                                                  
   
For the Six Months

Ended
     
   
July 2,
   
July 3,
   
Dollar
 
   
2023
   
2022
   
Change
 
             
   
(in millions)
 
Semiconductor Test
  $225.2   $327.5   $(102.3
System Test
   43.9    95.4    (51.5
Wireless Test
   21.4    44.0    (22.6
Robotics
   (44.9   (11.5   (33.4
Corporate and Eliminations (1)
   (4.1   (36.4   32.3 
   
 
 
   
 
 
   
 
 
 
   $241.5   $419.0   $(177.5
   
 
 
   
 
 
   
 
 
 
(1)
Included in Corporate and Eliminations are interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, legal and environmental fees, severance charges, pension, and an expense for the modification of Teradyne’s former chief executive officer’s outstanding equity awards.
The decrease in income before income taxes in Semiconductor Test was driven primarily by lower tester sales for Mobility and Compute applications, partially offset by higher Memory test sales in Flash Final Test. The decrease in income before income taxes in System Test was primarily due to lower sales in Storage Test of system level and hard disk drive testers. The decrease in income before income taxes in Wireless Test was driven primarily by a decrease in sales of connectivity test products. The decrease in income before income taxes in Robotics was driven primarily by softening demand due to slowing global industrial activity and macro-economic headwinds and the impact of the transformation of Universal Robots distribution channel. The decrease in loss before income taxes in Corporate and Eliminations was primarily due to legal settlement charges in 2022benefit related to litigation for the
earn-out
dispute in connection with the AutoGuide acquisition, changes in unrealized gains/losses on equity securities and higher interest income.
Income Taxes
The effective tax rate for the six months ended July 2, 2023 and July 3, 2022, was 15.7% and 14.1%, respectively. The increase in the effective tax rate from the six months ended July 3, 2022, to the six months ended July 2, 2023, was primarily attributable to a projected shift in the geographic distribution of income, which increases the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions and a reduction in discrete benefit from equity compensation. These increases were partially offset by an increase in benefit from the international provisions of the U.S. Tax Cuts and Jobs Act of 2017.

Contractual Obligations

There have been no changes outside of the ordinary course of business to our contractual obligations as disclosed in our Annual Report on

Form 10-K
for the year ended December 31, 2022.
35

2023.

Liquidity and Capital Resources

Our cash, cash equivalents and marketable securities balances decreased by $192.1$66.6 million in the sixthree months ended July 2, 2023,March 31, 2024, to $813.1$870.6 million.

Operating activities during the sixthree months ended July 2, 2023,March 31, 2024, provided cash of $162.1$7.3 million. Changes in operating assets and liabilities used cash of $121.7$108.6 million due to a $46.1$3.9 million increase in operating assets and a $75.5$104.7 million decrease in operating liabilities.

The increase in operating assets was primarily due to a $29.6an $8.1 million increase in prepayments and other assets due to prepayments to our contract manufacturers, a $13.8 million increase in inventories and a $2.7$6.9 million increase in accounts receivable.

receivable and inventories, respectively, partially offset by a $11.1 million decrease in other assets.

The decrease in operating liabilities was due to a $48.9$70.2 million decrease in accrued employee compensation a $34.9$28.4 million decrease in accounts payable, $7.0 million decrease in accrued other, $1.4 million decrease in deferred revenue and customer advance payments, a $13.6 million decrease in income taxes, and $2.5$1.4 million of retirement plan contributions, partially offset by a $13.0$3.8 million increase in accounts payable, and an $11.4 million increase in other accrued liabilities.

income taxes.

Investing activities during the sixthree months ended July 2, 2023,March 31, 2024, used cash of $121.7$24.0 million due to $99.0$44.0 million used for purchases of marketable securities, and $80.7 million used forthe purchases of property, plant and equipment, $16.0 million used for the purchase of marketable securities, partially offset by $35.6$20.7 million and $22.0 million in proceeds from sales and maturities of marketable securities, respectively, and $0.5$14.4 million in proceeds from the cancellationsale of Teradyne ownedmaturities and marketable securities, respectively, and $0.9 million in proceeds from life insurance policies related to the cash surrender value.insurance.

31


Financing activities during the sixthree months ended July 2, 2023,March 31, 2024, used cash of $283.2$36.7 million due to $227.8$22.1 million used for the repurchase of 2.20.2 million shares of common stock at an average price of $102.35$100.31 per share, $20.3 million used for payment related to net settlements of employee stock compensation awards, $34.2$18.4 million used for dividend payments and $17.5 million used for payments of convertible debt principal, partially offset by $16.6 million from the issuance of common stock under employee stock purchase and stock option plans.

Operating activities during the six months ended July 3, 2022, provided cash of $122.9 million. Changes in operating assets and liabilities used cash of $309.1 million. This was due to a $287.8 million increase in operating assets and a $21.3 million decrease in operating liabilities.
The increase in operating assets was due to a $146.4 million increase in accounts receivable, a $94.8 million prepayments and other assets due to prepayments to our contract manufacturers, and a $46.7 million increase in inventories.
The decrease in operating liabilities was due to a $61.7 million decrease in accrued employee compensation, a $6.9 million decrease in other accrued liabilities, and $2.6 million of retirement plan contributions, partially offset by a $25.0 million increase in accounts payable, a $14.2 million increase in deferred revenue and customer advance payments, and a $10.8 million increase in income taxes.
Investing activities during the six months ended July 3, 2022, used cash of $54.3 million due to $247.9 million used for purchases of marketable securities, and $89.7 million used for purchases of property, plant and equipment, partially offset by $139.7 million and $143.6 million in proceeds from maturities and sales of marketable securities, respectively.
Financing activities during the six months ended July 3, 2022, used cash of $626.8 million due to $532.8 million used for the repurchase of 5.0 million shares of common stock at an average price of $107.5 per share, $42.3 million used for payments of convertible debt principal, $35.4 million used for dividend payments, and $32.8$13.1 million used for payment related to net settlements of employee stock compensation awards, partially offset by $16.5$16.9 million from the issuance of common stock under employee stock purchase and stock option plans.

Operating activities during the three months ended April 2, 2023, provided cash of $19.3 million. Changes in operating assets and liabilities used cash of $106.5 million due to a $1.9 million increase in operating assets and $104.7 million decrease in operating liabilities.

The increase in operating assets was due to a $23.7 million increase in inventories, a $15.4 million increase in prepayments and other assets due to prepayments to our contract manufactures, partially offset by a $37.2 million decrease in accounts receivable.

The decrease in operating liabilities was due to a $93.1 million decrease in accrued employee compensation, a $32.7 million decrease in deferred revenue and customer advance payments, and $1.2 million of retirement plan contributions, partially offset by a $12.5 million increase in income taxes, a $9.6 million increase in accrued other liabilities, and a $0.3 million increase in accounts payable.

In January 20232024 and MayJanuary 2023, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.12 per share and $0.11 per share.share, respectively. Dividend payments for the three and six months ended JulyMarch 31, 2024 and April 2, 2023, were $17.0$18.4 million and $34.2$17.2 million, respectively.

In January 2022 and May 2022, Teradyne’s Board of Directors declared a quarterly cash dividend to $0.11 per share. Dividend payments for the three and six months ended July 3, 2022, were $17.5 million and $35.4 million, respectively.

In January 2023, our Board of Directors cancelled the 2021 repurchase program and approved a new repurchase program for up to $2.0 billion of common stock. We intend to repurchase up to $500.0 million of common stock in 2023 subject to market conditions.

36

During the sixthree months ended July 2, 2023,March 31, 2024, we repurchased 2.20.2 million shares of common stock for $227.8$22.1 million, which excludes related excise tax, at an average price of $102.35$100.31 per share. DuringWe intend to repurchase up to $90.0 million of common stock in 2024 subject to market conditions. The cumulative repurchases under the six months ended July 3, 2022, we repurchased 5.02023 repurchase program as of March 31, 2024 were 4.1 million shares of common stock for $532.8$419.4 million, which excludes related excise tax, at an average price per share of $102.35. During the three months ended April 2, 2023 , we repurchased 0.9 million shares of common stock for $93.3 million, which excludes related excise tax, at an average price of $107.50$104.88 per share.

While we have previously declared a quarterly cash dividend and authorized a share repurchase program, we may reduce or eliminate the cash dividend or share repurchase program in the future. Future cashCash dividends and stock repurchases are subject to the discretion of our Board of Directors, which will consider, among other things, our earnings, capital requirements and financial condition.

On May 1, 2020, we entered into a credit agreement providing a three-year, senior secured revolving credit facility of $400 million. On December 10, 2021, the credit agreement was amended to extend the senior secured revolving credit facility to December 10, 2026. On October 5, 2022, the credit agreement was amended to increase the amount of the credit facility to $750.0 million from $400.0 million. As of August 4, 2023,May 3, 2024, we have not borrowed any funds under the credit facility.

We believe our cash, cash equivalents, marketable securities and senior secured revolving credit facility will be sufficient

to
pay
our
quarterly dividend and meet our working capital and expenditure needs for at least the next twelve months. Inflation has not had a significant long-term impact on earnings. At this time, the
COVID-19
pandemic has not had an impact on our liquidity, but there is no assurance that continued impacts resulting from the pandemic will not have an adverse effect in the future.

Equity Compensation Plans

In addition to our 1996 Employee Stock Purchase Program as discussed in Note Q: “Stock-Based Compensation” in our 20222023 Annual Report on Form

10-K,
we have a 2006 Equity and Cash Compensation Incentive Plan (the “2006 Equity Plan”).

The purpose of the 1996 Employee Stock Purchase Plan is to encourage stock ownership by all eligible employees of Teradyne. The purpose of the 2006 Equity Plan is to provide equity ownership and compensation opportunities in Teradyne to our employees, officers and directors. Both plans were approved by our shareholders.

Recently Issued Accounting Pronouncements

For

In November 2023, the six months ended July 2,Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures", which will require us to disclose

32


significant segment expenses and other segment items used by the Chief Operating Decision Maker ("CODM") on an annual and interim basis as well as provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Additionally, we will be required to disclose the title and position of the CODM. The new standard is effective for fiscal years beginning after December 15, 2023, there wereand interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. This ASU will have no recentlyimpact on our results of operations, cash flows or financial condition. Upon adoption, we will apply the amendments in this ASU retrospectively to all prior period disclosures presented in the financial statements.

In December 2023, FASB issued accounting pronouncements that had,ASU 2023-09 –“Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which requires expanded disclosures relating to the tax rate reconciliation, income taxes paid, income (loss) before income tax expense (benefit) and income tax expense (benefit), requiring a greater disaggregation of information for each. The provisions of ASU 2023-09 are effective for fiscal years beginning after December 15, 2024. The amendments in this update should be applied on a prospective basis, but retrospective application is permitted. This ASU will have no impact on results of operations, cash flows or are expected to have, a material impact to our consolidated financial statements.

Item 3:
Quantitative and Qualitative Disclosures about Market Risks
condition.

Item 3: Quantitative and Qualitative Disclosures about Market Risks

For “Quantitative and Qualitative Disclosures about Market Risk” affecting Teradyne, see Part 2 Item 7A, “Quantitative and Qualitative Disclosures about Market Risks,” in our Annual Report on Form

10-K
filed with the SEC on February 22, 2023.2024. There were no material changes in our exposure to market risk from those set forth in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2022.
In addition to market risks described in our Annual Report on Form
10-K,
we have an equity price risk related to the fair value of our convertible senior unsecured notes issued in December 2016. In December 2016, Teradyne issued $460 million aggregate principal amount of 1.25% convertible senior unsecured notes (the “Notes”) due December 15, 2023. As of July 2, 2023, $32.8 million of principal remained outstanding

Item 4: Controls and the Notes had a fair value of $115.8 million. The table below provides a sensitivity analysis of hypothetical 10% changes of Teradyne’s stock price as of the end of the second quarter of 2023 and the estimated impact on the fair value of the Notes. The selected scenarios are not predictions of future events, but rather are intended to illustrate the effect such event may have on the fair value of the Notes. The fair value of the Notes is subject to equity price risk due to the convertible feature. The fair value of the Notes will generally increase as Teradyne’s common stock price increases and will generally decrease as the common stock price declines in value. The change in stock price affects the fair value of the Notes, but does not impact Teradyne’s financial position, cash flows or results of operations due to the fixed nature of the debt obligation. Additionally, we carry the Notes at face value less unamortized discount on our balance sheet, and we present the fair value for required disclosure purposes only. In connection with the offering of the Notes we also sold warrants to the option counterparties. These transactions have been accounted for as an adjustment to our shareholders’ equity. The convertible note hedge transactions are expected to reduce the potential equity dilution upon conversion of the Notes. The warrants along with any shares issuable upon conversion of the Notes will have a dilutive effect on our earnings per share to the extent that the average market price of our common stock for a given reporting period exceeds the applicable strike price or conversion price of the warrants or Notes, respectively.

37

Hypothetical Change in Teradyne Stock Price
  
Fair Value
   
Estimated change
in fair value
   
Hypothetical
percentage
increase (decrease)
in fair value
 
             
10% Increase
  $127,385   $11,607    10.0
No Change
   115,778    —      —   
10% Decrease
   104,171    (11,607   (10.0
Item 4:
Controls and Procedures
Procedures

As of the end of the period covered by this report, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule

13a-15(b)
or Rule
15d-15(f)
promulgated under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that material information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, including ensuring that such material information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There have been no changes in our internal control over financial reporting (as defined in Rules

13a-15(f)
and
15d-15(f)
under the Exchange Act) during the three months ended July 2, 2023,March 31, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

33


PART II. OTHER INFORMATION

Item 1:
Legal Proceedings

Item 1: Legal Proceedings

We are subject to various legal proceedings and claims which have arisen in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. Teradyne believes that it has meritorious defenses against all pending claims and intends to vigorously contest them. While it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, Teradyne believes the potential losses associated with all of these actions are unlikely to have a material adverse effect on its business, financial position or results of operations.

On March 8, 2021, Industrial Automation LLC submitted a demand for arbitration against Teradyne and AutoGuide in Wilmington, Delaware alleging that Teradyne and AutoGuide breached certain provisions of the Membership Interests Purchase Agreement (the “Purchase Agreement”), dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide. The arbitration demand sought full acceleration of the maximum
earn-out
amount payable under the Purchase Agreement, or $106.9 million, for the alleged breach of the
earn-out
provisions of the Purchase Agreement. On March 25, 2022, the arbitration claim was settled for $26.7 million. As a result, Teradyne has no remaining
earn-out
obligations.
Item 1A:
Risk Factors

Item 1A: Risk Factors

In addition to other information set forth in this Form

10-Q,
including the risk discussed below, you should carefully consider the factors discussed in Part I, “Item 1A: Risk Factors” in our Annual Report on Form
10-K
for the year ended December 31, 2022,2023, which could materially affect our business, financial condition or future results. The risk factors described in our Annual Report on Form
10-K
remain applicable to our business and many of these risks could be further increased due to the
COVID-19
pandemic.
business.

The risks described in our Annual Report on Form

10-K
are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

34


Adverse developments affecting the financial services industry, including events or risks involving liquidity, defaults or
non-performance

by financial institutions, could have a material adverse effect on our business, financial condition or results

Item 2: Unregistered Sales of operations.

On March 10, 2023,
Silicon Valley Bank
(SVB), who is a lender in our revolving credit facilityEquity Securities and where we maintain certain accounts and cash deposits, was placed into receivership with the Federal Deposit Insurance Corporation (FDIC), which resulted in all funds held at SVB being temporarily inaccessible by SVB’s customers. AsUse of March 13, 2023, access to our cash and cash equivalents at SVB was fully restored. Although our cash balances at SVB are insignificant and we do not expect further developments at SVB to have a material impact on our cash and cash equivalents, we do hold cash balances in several large financial institutions significantly in excess of FDIC and global insurance limits. If other banks and financial institutions with whom we have banking relationships enter receivership or become insolvent in the future, we may be unable to access, and we may lose, some or all of our existing cash, cash equivalents and investments to the extent those funds are not insured or otherwise protected by the FDIC.
38

Item 2:
Unregistered Sales of Equity Securities and Use of Proceeds
Proceeds

In January 2023, Teradyne’s Board of Directors cancelled our 2021 repurchase program and approved a new repurchase program for up to $2.0 billion of common stock. During the sixthree months ended July 2, 2023,March 31, 2024, we repurchased 2.20.2 million shares of common stock for a total cost of $229.5$22.1 million at an average price of $102.35$100.31 per share. We record share repurchases at cost, which includes broker commissions and related excise taxes. During the sixthree months ended July 3, 2022,April 2, 2023, we repurchased 5.00.9 million shares of common stock for $532.8$93.7 million at an average price of $107.5$104.88 per share.

The following table includes information with respect to repurchases we made of our common stock during the three and six months ended July 2, 2023,March 31, 2024, (in thousands except per share price):

Period

 

Total
Number of
Shares
(or Units)
Purchased

 

 

 

Average
Price Paid per
Share (or Unit)

 

 

 

Total Number of
Shares (or Units)
Purchased as Part of
Publicly Announced
Plans or Programs

 

 

Maximum Number
(or Approximate Dollar
Value) of Shares (or
Units) that may Yet Be
Purchased Under the
Plans or Programs (2)

 

January 1, 2024 - January 28, 2024

 

 

22

 

 

 

$

110.59

 

 

 

 

 

 

$

1,599,497

 

January 29, 2024 - February 25, 2024

 

 

229

 

 

 

$

101.92

 

 

 

 

130

 

 

$

1,586,608

 

February 26, 2024 - March 31, 2024

 

 

92

 

 

 

$

102.51

 

 

 

 

90

 

 

$

1,577,380

 

 

 

343

 

(1)

 

 

102.65

 

(1)

 

 

220

 

 

 

 

(1)
Includes approximately one hundred twenty two thousand shares at an average price of $106.86 withheld from employees for the payment of taxes.
(2)
As of January 1, 2023, share repurchases net of share issuances are subject to a 1% excise tax under the Inflation Reduction Act. Excise tax incurred is included as part of the cost basis of shares repurchased in the Condensed Consolidated Statements of Convertible Common Shares and Stockholders’ Equity.
Period
  
Total

Number of

Shares

(or Units)

Purchased
      
Average

Price Paid per

Share (or Unit)
  
Total Number of

Shares (or Units)

Purchased as Part of

Publicly Announced

Plans or Programs
   
Maximum Number

(or Approximate Dollar

Value) of Shares (or

Units) that may Yet Be

Purchased Under the

Plans or Programs (2)
 
                   
April 3, 2023 – April 30, 2023
   410       $100.73   409   $1,865,063 
May 1, 2023 – May 28, 2023
   469       $92.88   467   $1,821,664 
May 29, 2023 – July 2, 2023
   474       $108.31   473   $1,770,455 
   
 
 
       
 
 
  
 
 
      
    1,354(1)       $100.66(1)   1,349      
   
 
 
       
 
 
  
 
 
      
(1)
Includes approximately four thousand shares at an average price of $97.95 withheld from employees for the payment of taxes.
(2)
As of January 1, 2023, share repurchases net of share issuances are subject to a 1% excise tax under the Inflation Reduction Act. Excise tax incurred is included as part of the cost basis of shares repurchased in the Condensed Consolidated Statements of Convertible Common Shares and Stockholders’ Equity.

We satisfy U.S. federal and state minimum withholding tax obligations due upon the vesting and the conversion of restricted stock units into shares of our common stock, by automatically withholding from the shares being issued, a number of shares with an aggregate fair market value on the date of such vesting and conversion that would satisfy the minimum withholding amount due.

Item 4:
Mine Safety Disclosures

Item 4: Mine Safety Disclosures

Not Applicable

35


Item 5:
Other Information
10b5-1

Item 5: Other Information

10b 5-1 Trading Plans

Our officers (as defined in Rule

16a-1(f)
under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (“Section 16 Officers”) and directors from time to time enter into contracts, instructions or written plans for the purchase or sale of our securities that are intended to satisfy the conditions specified in Rule
10b5-1(c)
under the Exchange Act for an affirmative defense against liability for trading in securities on the basis of material nonpublic information. We refer to these contracts, instructions, and written plans as “Rule
10b5-1
trading plans” and each one as a “Rule
10b5-1
trading plan.” During our
fiscal quarter
ended
July 2, 2023
, March 31, 2024, the following Section 16 Officers andor directors adopted, modified or terminated Rule
10b5-1
trading plans:
Sanjay Mehta, Chief Financial Officer and Treasurer
Sanjay Mehta,

Richard Burns, President, Semiconductor Test

Richard Burns, our Chief Financial Officer and Treasurer,President, Semiconductor Test, entered into a new Rule

10b5-1
trading plan on May 12, 2023.February 15, 2024. The Rule
10b5-1
trading plan provides that Mr. Mehta,Burns, acting through a broker, may sell up to an aggregate of (i) 19,494 shares of our common stock, (ii) 100%50% of the (net) shares resulting from the vesting of 16,60310,759 (gross) restricted stock units (net shares are net of tax withholding), and (iii)
100
%(ii) 100% of the (net) shares resulting from the exercise of up to 8,8278,700 stock options (net shares are net of the stock option exercise prices). Subject to price limits, the first trade under theMr. Burns’s Rule
10b5-1
trading plan is scheduled for August 14, 2023. TheMay 20, 2024. Mr. Burns’s plan is scheduled to
terminate on May 3, 2024,February 28, 2025, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. MehtaBurns or the broker, or as otherwise provided in the plan.

Mercedes Johnson, Director

Mercedes Johnson, a member of our Board of Directors, entered into a new Rule 10b5-1 trading plan on February 2, 2024. The Rule 10b5-1 trading plan provides that Ms. Johnson, acting through a broker, may sell up to an aggregate of 7,500 shares. Subject to price limits, the first trade under Ms. Johnson’s Rule 10b5-1 trading plan is scheduled for June 3, 2024. Ms. Johnson’s plan is scheduled to terminate on April 30, 2025, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Ms. Johnson or the broker, or as otherwise provided in the plan.

plan.
39

36


Item 6: Exhibits

Item 6:

Exhibit

Number

Exhibits

Description

Exhibit

Number

Description

10.1

Form of Time-Based Restricted Stock Unit Agreement for Executive Officers under the 2006 Equity and Cash Compensation Incentive Plan, as amended* (filed herewith)

31.1

10.2

Form of Executive Officer Stock Option Agreement under the 2006 Equity and Cash Compensation Incentive Plan, as amended* (filed herewith)

31.1

Certification of Principal Executive Officer, pursuant to Rule 13a-14(a) of Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

31.2

Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) of Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

32.1

Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)

32.2

Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema DocumentWith Embedded Linkbase Documents

101.CAL

104

Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104

Cover Page Interactive Data File (formatted as Inline XBRL, and contained in Exhibit 101)

40

37


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

TERADYNE, INC.

TERADYNE, INC.

Registrant

Registrant

/s/ SANJAY MEHTA

/s/ S
ANJAY
M
EHTA

Sanjay Mehta

Vice President,

Chief Financial Officer and Treasurer

(Duly Authorized Officer

and Principal Financial Officer)

August 4, 2023

May 3, 2024

38


41